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Ecological interface design (EID; Vicente & Rasmussen, 1992) is a discipline 
that emphasizes the necessity of understanding the laws and constraints of a 
domain in order to make meaningful design decisions. We applied EID principles to 
create an ecological interface aimed at helping physicians with the detection, 
evaluation, and treatment of cardiovascular disease risk (specifically for 
hypertension and hyperlipidemia) and then evaluated it in two exploratory studies.  
In the first study, twenty-three internal medical residents participated viewed data 
from twelve patients (in six blocks) in a repeated measures study that measured 
which risk factors participant felt required follow-up and if their treatment 
decisions agreed with medically established guidelines (e.g., ATP-III for 
hyperlipidemia and JNC-7 for hypertension). The results indicate that residents 
were significantly more likely to follow up on metabolic syndrome when using the 
ecological display (p <. 0004) and that in 3 of the 6 trial blocks, they were more 
likely to choose treatment decisions that agreed with medical guidelines when using 
the ecological display for LDL cholesterol.  Two faculty and two residents 
participated in our follow-up study, which included a simplified version of the first 
study but utilized an interactive version of the display and where performance and 
 
 v 
interactions were recorded and analyzed.  It also included interviews regarding 
usability issues. The results demonstrated a preference for greater guideline 
agreement when using the ecological display in only one block of trials, even though 
almost all participants reported high levels of confidence that their decisions were 
in agreement with medical guidelines. The usability interviews suggested many 
ways in which the ecological display could be changed in future re-designs in order 
to better serve various user groups and purposes. The many positive reactions from 
our participants, in conjunction with our results, suggest that that further design 
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1.1. Medieval Medicine 
From the vantage of over 600 years of history, it is easy to look back at the 
medieval times with some degree of cynicism about medical beliefs and knowledge 
of that time.  Mortimer (2008) suggests that modern people would likely view 
medieval English medicine as “a bizarre mixture of arcane ritual, cult religion, 
domestic invention, and freakshow” (pp. 191). 
Medieval physicians (university trained) and doctors (not university trained) 
relied heavily on various books and manuals to aid the diagnosis and treatment 
process, which process Mortimer describes in the following: 
“[Their manuals] include details of planets’ movements and eclipses of the 
sun and moon.  They also include advice about phlebotomy (letting blood) 
and all twenty-four varieties of urine, as well as numerological methods of 
establishing whether you are likely to die or not.  The physician will need to 
know when your illness started, so he can establish where the sun and moon 
were at the time, as well as the planet governing the health of the inflicted 
organ.  Using these details, he will prepare a series of concoctions for you.  
First, there is the purgative, to rid it of corrupt matter, either through 
vomiting, defecation, or urination.  Then there is the remedy.  Alternatively 
the physician may open a vein and let your blood.  From his diagrams he will 
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work out exactly which vein to cut in order to bleed you appropriately.  This 
has as much to do with the moon and stars as with your symptoms.  When 
the moon is in Leo, he should avoid incisions of the nerves and the back.  […] 
When it is in Scorpio, he should avoid slicing into your testicles, anus, and 
bladder.  […] After the ordeal is over, you should expect him to advise a final 
restorative process […]“ (p.  211). 
If your remedy process includes a concoction rather than bloodletting, your 
options might include consuming such colorful and questionable (by today’s 
standards) treatments such as seven fat bats heads for diseases of the spleen or 
flayed cat cooked in hedgehog and bear fat for quinsy (Mortimer, 2008). 
Again, while English medieval medicine seems backwards to the modern 
reader, Mortimer makes it a point to note that,  
“Medieval people are not ignorant, in the sense of having no knowledge.  It is 
simply that their knowledge is very different from our own.  They probably 
have as much medical “knowledge” as we do, only it is based on astrology, 
herbology, religion, a little direct experience, philosophy, fundamental 
misconceptions about how the body works, a lot of hearsay, and a large 
measure of desperation.  When you extend this form of understanding to the 
physicians and surgeons, and combine it with the ability to charge fees, you 
realize that medical practitioners have colossal amounts of information at 
their disposal and a wealth of experience.  Unfortunately, not much of it will 
help you in your sickness, and some of it is seriously dangerous, if not lethal 
(p.  193).” 
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Medieval English physicians required years of training and education to earn 
a medical degree in a manner somewhat similar to the physicians of today.  
However, as Mortimer puts it, the difference between them and our physicians of 
today was not in the amount of knowledge per se.  Medieval physicians and doctors 
had to consider the relationships of many variables in order to arrive at the proper 
diagnosis and treatment plan just as the physicians of today do.  The difference lies 
primarily in the quality of their “knowledge.”  
Today’s physicians do not have to rely on astrology, philosophy, hearsay, and 
desperation because they have benefited from advances in anatomy and physiology 
that have been a result of advances in science. Improved scientific methods have 
allowed for the accumulation of a great wealth of medical knowledge that is more 
firmly grounded in ideas and scientific models (i.e., “the Truth”) that lead to more 
successful outcomes for the patient. This scientific medical knowledge is the heart of 
what is known as evidence-based medicine.   
1.2. Evidence-Based Medicine & Practice 
Timmermans and Mauck (2005) remark that evidence-based medicine is 
broadly applied to many aspects of medicine including “conducting a statistical 
meta-analysis of accumulated research, promoting randomized clinical trials, to 
supporting uniform reporting styles for research, to a personal orientation toward 
critical self-evaluation” (p. 18). Sackett, Rosenberg, Muir Gray, Haynes, and 
Richardson (1996) define it as “the conscientious, explicit, and judicious use of 
current best evidence in making decisions about the care of individual patients” (p.  
71). This definition focuses more on the provision of care rather than on the 
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discovery of knowledge, which provides it with a practical slant.  This definition 
provides a good definition of what could be called evidence-based practice.   
One of the problems facing physicians wishing to engage in evidence-based practice 
is simply keeping up with the evidence base.  The homepage for PubMed, a database 
for scientific literature focused on biomedicine, boasts that it is comprised of over 
22 million citations and growing (United States Library of Medicine [NLM], n.d.).  
Even if a physician spent all of their time reading published research, there is 
obviously no possible way that they could read and absorb everything.  Expert 
panels and committees help reduce some of the burden by creating guidelines and 
best practices based on the literature.  However, there is still a tremendous load on 
the modern medical practitioner to stay up to date.   
1.3. Information Technology 
Modern information technological solutions, such as electronic medical 
record (EMR) systems, have great potential to help with information management.  
Health information technology (HIT) can be programmed to take the most recent 
medical evidence into account and provide support to physicians who access these 
systems.  These electronic systems can increase efficiency and potentially reduce 
physicians’ cognitive load by automatically integrating data in meaningful ways: for 
example, automatically calculating values such as body mass index (BMI) and 10-
year risk of cardiovascular disease (CVD) for the physician or by alerting the 
physician to indicate that certain values fall outside of pre-specified boundary 
conditions.   
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Off-loading some of the overwhelming amount of medical knowledge 
requirements to HIT is a way of taking knowledge that would normally be expected 
to be “in the head” and transferring it to “the world” (Norman, 1988).  Designing HIT 
systems to collaborate with and support human expertise leads to the creation of a 
socio-technical system known as a distributed cognitive system (Lintern, 2007; 
Hutchins, 1995; Hollan, Hutchins, & Kirsch, 2000).  A major benefit of a distributed 
cognitive system is that it reduces the tremendous cognitive load expected of a 
single agent (i.e., the physician) for proper system performance (i.e., providing care 
based on scientific evidence).   
Practicing evidence-based medicine requires that physicians have access to 
(1) patient data, (2) scientific knowledge of how to interpret the patient data, and 
(3) information about the possible treatment options.  If any of these three 
components is degraded, then there is a significant possibility that the patient’s care 
will be less than satisfactory.  While the information technologies supporting 
evidence-based medicine promise improved access to patient data, there is concern 
that insufficient attention is being paid to the other components.  Thus, there is a 
fear that physicians may be simply overwhelmed with data, with little improvement 
in their capacity to make better treatment decisions.  If medical data is not 
interpreted properly, it does little to aid understanding and is therefore not 
informative and fails to meet its ultimate objective.  Although data from medical 
tests undoubtedly helps providers and patients make informed decisions that help 
improve diagnosis and treatment, there are some issues in the interpretation 
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process that can lead to data failing to become informative, resulting in potentially 
negative outcomes in diagnosis and treatment. 
1.4. Representations of Patient Data and Error 
In previous research, we observed one physician review the test results of 
about 12 patients in less than 10 minutes.  While not able to ascertain the accuracy 
of that physician’s performance, the speed at which that task was performed might 
explain why the physicians in that office occasionally signed abnormal test results 
off as normal (McEwen, Elder, & Flach, 2011).   
Currently, most laboratory results are reported using alphanumeric 
characters in a tabular format (see Figure 1).  Given the similarities in the 
alphanumeric characters it is not surprising that data is occasionally misinterpreted 
or missed, leading to errors in decision-making.   
Reason (1990) distinguishes between two types of error: slips and mistakes.  
Physicians, like all humans, are prone to these types of error.  In the context of 
interpreting test results, a slip can occur when the provider intends to read the 
numerical value for a particular biochemical (e.g., total protein), but instead 
accidentally reads the value from the line above or below the correct value (e.g., 
albumin).  A mistake, on the other hand, is a well-executed erroneous plan.  That 
erroneous plan, in turn, may have been the result of the aforementioned slip 
example or due to the fact that the amount of data that must be considered taxes the 
human mental capacity.   
Healthcare providers often deal with data that is ambiguous (e.g., does the 
patient’s cough indicate a viral or bacterial infection?).  In some cases, many pieces 
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of information across multiple channels (such as multiple medical tests and patient 
vital statistics) must be integrated, or prior history must be considered before a 
proper interpretation can be made.  Given the ambiguity inherent in patient health 
data and the difficulty integrating multiple independent sources of data, it is 
possible for providers to draw the wrong conclusions and misdiagnose the patient’s 
condition, potentially leading to a decline in the quality of care. 
 
Figure 1 Example of Commonly Ordered Laboratory Test Results  
1.5. Graphics as an Alternative 
The general hypothesis motivating this research is our belief that alternative 
means of data presentation, such as graphics, can potentially aid physicians to gain a 
deeper understanding of the relationships in the data (Tufte, 2001).  Specifically, we 
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propose to more effectively integrate patient data with the scientific evidence-base 
concerning judgments about health and choices of treatment options.  Our general 
goal is to explore ways to better support evidence based practice through integral 
graphic displays.  The same information technologies that facilitate storage and 
access of patient data offer significant opportunities to improve how that data can 
be represented. 
Graphics can have a positive impact on improving the accuracy and decision-
making of providers and patients.  Although some recommendations for improving 
graphical displays of patient information have been made (see Figure 2; Douglas & 
Caldwell, 2009), there are very few examples that have been actually implemented.  
These few graphical displays—which have been developed in both academia and 
popular culture (Leckart, 2010; Goetz, 2011)—are likely to have some advantages 
over the alphanumeric format, but they remain at their core, fairly simple number 
lines, bar graphs, or line graphs.  These formats can make the search for abnormal 
values quicker and more accurate, but they do little to integrate the data to reflect 
the scientific knowledge base related to diagnosis and treatment.  Thus, while 
improving access to data, they may fall far short of the full potential to improve the 




Figure 2  Individual Health Report Example (Douglas & Caldwell, 2009) 
1.6. Purpose and Design Limitations 
Current graphical displays for medical information have generally employed 
a single-sensor-single-indicator format that improves access to specific data, but 
that provides little structure for integrating that data to reflect underlying relations 
that may be critical to understanding more global properties, such as the overall 
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health of the patient or the relative merits of various treatment options.  Ecological 
or semantic display design (Bennett & Flach, 2011; Vicente & Rasmussen, 1992) is 
an approach to interface development that emphasizes the integration of 
information to support effective decision-making and problem solving.  Thus, this 
brings us to the purpose of this dissertation research—to discuss the development 
process and evaluation of an ecological graphical display that can be used to detect, 
evaluate, and treat issues related to cardiovascular disease in a way that supports 
clinicians in evidence-based practice.   
The success of the ecological approach depends on the value of the underlying 
scientific evidence-base.  For example, an ecological approach applied to medieval 
medicine would still not have produced an as effective of a display as one based on 
modern medical knowledge. The effectiveness of evidence-based practice will 
always be bounded by the quality of the underlying scientific models of 
cardiovascular disease and treatment.   
The goal of this research is simply to ensure that clinical decisions about CVD are 
informed by the existing evidence-base.  It is important not to confuse this work 
with another potential goal for electronic medical systems – that is, to improve the 
evidence-base through improved representations/models for medical researchers 
(e.g., epidemiologists).  This alternative goal is typically referred to as ‘scientific 
visualization.’ While ecological interface design seeks to configure graphical displays 
to represent patterns that reflect current scientific knowledge (i.e., existing models 
of health), the goal of scientific visualization is to help medical researchers to 
discover previously undetected patterns in the data (i.e., new models of health).  For 
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example, our display is not aimed at helping cardiologists discover new 
cardiovascular risk variables in the data. Instead we are focused on creating 
something that can help early and mid-career primary care practitioners see the 
data in the light of the health models and guidelines for treatment so that they can 
use this information as the starting point in the decision making process.  
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2. ECOLOGICAL INTERFACES AND SEMIOTICS
2.1. Ecological Interfaces 
What is an ecological interface? It is important, first, to understand what it is 
not. Some erroneously believe that ease-of-use or simplicity define an ecological 
display. This is not true. An ecological display may require significant training 
before use because the system being represented may be extremely complicated 
and complex. It would be ideal if an ecological display could be so intuitive that no 
training would be required, but the designer must balance this with the need to 
represent the intricacies of the domain in question. In other words, the law of 
requisite variety must be respected (Ashby, 1958), or else the display runs the risk 
of inadequately representing the work domain and runs the risk of being unhelpful 
or irrelevant at times. Neither the display nor designer should trivialize the work 
domain in order to develop an overly simple display at the expense of one that 
accurately reflects the work and the domain. 
Bennett & Flach (2011) have defined an ecological display as an interface 
that “must provide global and local structure (or invariants) in the representation that 
correspond to the inherent structure in the domain and that specify the potential in 
the relation to goals and values” [p. 137; italics in original]. In other words, it is an 
interface or display that attempts to connect the underlying ecology (the structure, 
rules, laws, regulations, opinions, etc.) of the domain to the graphical elements.  
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2.2. Semantic Mapping 
The definition provided by Bennett and Flach (2011) may be understood 
more readily by understanding the concept of semantic mapping, which is the 
fundamental principle of ecological display design. McGregor and Slovic (1986) 
demonstrated the role of semantic mapping with a series of studies that required 
participants to estimate runners’ marathon times using multiple low-level cues 
about each runner (i.e., age, fastest 10K race time in the past year, number of miles 
run for training in the 2 months prior to the marathon, and motivation).  
In their first study, participants evaluated several graphical display types 
(e.g., a bar graph, polar coordinate, deviation display, and Chernoff face) to 
investigate which provided superior support to the time estimation task. Each of 
these display formats had the various marathon run time cues mapped to the 
various graphical elements. For instance, the cues were represented as the height of 
a bar in the bar graph or the curvature of the mouth (or other facial feature) in the 
Chernoff face display. The results of the first study indicated that participants were 
more accurate when the using the Chernoff face displays. These results might lead 
one to believe that this represents the power of configural or “object” displays.  
Although the Chernoff face display led to more accurate responses, there was 
some uncertainty about the reason. Was it due to the fact that the Chernoff faces 
allowed all cues to be represented simultaneously in an integrated framework that 
allowed for parallel processing (i.e., because it was a perceptually integrated 
“object”), or was it due to something else? McGregor and Slovic considered that 
there might be another reason for the performance difference, namely that some 
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facial features in the Chernoff faces were more salient than others (e.g. the mouth 
curvature versus the height of the nose), which might lead participants to give more 
credence to the cues that were mapped onto the more salient features. If parallel 
processing and an integrated framework for the cues were the reason for more 
accurate estimates, then similar performance should be obtained for any feature-to-
cue mapping. After all, all cues would be presented as an “object” display and share 
whatever benefits gained from that format.  
To test the effect of facial feature-to-cue mapping, McGregor and Slovic 
conducted a second study in which they represented information from the same 
marathon runners, but had mapped the cues in one of two mapping schemes: a well-
mapped face and a poorly-mapped face. The well-mapped face display was designed 
so that the more indicative the cue was (as measured by the amount of variance that 
could be explained), the more salient the facial cue (as derived from Brunswick’s 
lens model) assigned to it was. The poorly-mapped display took the opposite 
approach and mapped the more predictive cues to the least salient facial cues. These 
reverse mappings led to cases where the same information could result in extremely 
different faces (see Figure 3).  
The results of the second study found that the well-mapped faces led to 
better performance than the poorly-mapped displays. In fact, the poorly-mapped 
facial display led to worse performance than some of the original formats presented 
in their first experiment, such as the deviation and polar-coordinate display. These 
findings suggest that the superiority of the Chernoff face display was not due to the 
fact that all cues were placed together in a coherent framework that allowed for 
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parallel processing. If so, then both the poorly- and well-mapped faces should have 
led to similar outcomes. The fact that the same information presented in the same 
graphical format could lead to disparate results is evidence that the mapping 
between cues from the domain (e.g., running marathons) and display elements is 
meaningful. It is this relationship between the domain and graphical elements that 
is known as semantic mapping or semantics. 
2.3. Semiotics 
What do semantics have to do with graphical displays? To answer this 
question, it is important to have an understanding of semiotics, or the study of signs 
and signifying, because the creation of a graphic display is the creation of Signs 
(Nadin, 1988).  
2.3.1. Dyadic Systems 
A dyadic semiotic system is comprised of a Sign and a Concept (see Figure 4). 
The Sign is sometimes referred to as a medium, representation, or interface. The 
Concept is a belief, mental model, or knowledge that an agent has. Knowing what a 
literal sign (such as a stop sign) means is a question of semiotics as is arriving at a 
medical diagnosis. In both cases, an agent or observer must make sense of the Sign. 
In a dyadic semiotic system, a physician would examine a patient’s symptoms (the 
Sign) and arrive at a diagnosis and treatment plan (the Concept). Under a strictly 
dyadic semiotic model, any diagnosis would be valid as long as the 
diagnosis/treatment matched the symptom, such as prescribing antibiotics for a 
patient who has all of the symptoms of a cold. In other words, the dyadic model 
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Figure 4 Model of a Dyadic Semiotic System 
However, most healthcare providers would probably believe that prescribing 
antibiotics to treat the patient’s symptoms would be ludicrous without further 
investigation because there would be no guarantee that the symptoms would be tied 
the patient’s health and disease pathogenesis. The symptoms do not specify whether 
they are the result of a bacterial, viral, or allergic origin. Instead, the semiotic model 
must be expanded to include the health of the patient and the pathogenesis of the 
disease in order to provide the appropriate care to the patient. By broadening the 
semiotic system to include the health and pathogenesis, the dyadic model becomes a 
triadic model (Pierce, 1931-1935; see Figure 5) by adding another circle to the 
semiotic model. This third circle, representing the Ecology (e.g., the health and 
pathogenesis of the patient), now allows the diagnosis to be mapped to something 
























Figure 5 Model of a Triadic Semiotic System 
In the first study by McGregor and Slovic, they hypothesized that the 
marathon time estimate (i.e., Concept) should be more accurate with some graphical 
display formats (i.e., Signs) than with others. The supposed reason for any 
differences in display performance would be that there was something inherently 
superior about the Sign that allowed the viewer to form a better Concept, such as 
providing an integrated framework allowing for parallel processing. This reasoning 
is dyadic.  
However, the second study illustrated that even the same graphical format 
can lead to different time estimates. That different times could result from the same 
format is strong evidence that the time estimate must be based on something else in 
addition to the display. It is difficult to describe what this other “thing” might be 
within a dyadic framework because the dyadic ontology is limited to only the Sign 
and Concept. A triadic framework can account for these findings by considering the 



























domain of marathon running and the cues that predict run times. The second study 
demonstrates that the relationship between the Ecology and the Sign (i.e., the 
variance accounted for in the cues and the salience of the facial features in the 
display) was meaningful for participants. This meaningful relationship does not 
exist in a dyadic semiotic system because it does not exist within the ontology.   
2.3.2. Triadic Systems 
In a triadic system, the relationship between Ecology and Sign is known as 
Meaning, while the relationship between Sign and Concept is the Interpretation 
(Bennett & Flach, 2011). In a dyadic system, Meaning and Interpretation are 
equivalent terms because the dyadic ontology does not contain more than one 
relationship.  
The traditional approach to display design has primarily been a dyadic 
systems approach. In a dyadic framework of display design, the semiotic problem is 
how to create a Sign that is related to the Concept (i.e. the focus is on the 
Interpretation). This relationship usually takes form in the preoccupation of 
ensuring that graphs and displays are utilizing the optimum colors, proper sizes, 
proper positioning, type of graph (e.g., bar versus line graphs), proper typefaces, 
etc., so that the observer can understand the display. However, just as a diagnosis 
would be shortsighted if only the Interpretation relationship was considered, a 
graphical display format would also be equally shortsighted if this were the case.  
All graphical displays have a mapping between the Concept, Sign, and 
Ecology, but if no effort is taken to ensure a quality mapping between the Sign and 
the Ecology, then the mapping is arbitrary. This was the case in the first study in 
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McGregor and Slovic (1986); their initial results that led to the superiority of the 
Chernoff face format was the result of the accidental initial arbitrary mapping of 
facial features to risk factors. If another mapping had been used for the facial 
displays instead, the second study may very well have been a follow-up on one of 
the other graphical formats.  
Effective display design requires a conscious effort to map the display 
features to the factors that are relevant to the domain “behind” the display (i.e., 
semantic map). Semantic mapping is the alignment of Interpretation and Meaning. It 
changes the focus from getting an observer to understand the display to that of 
understanding the domain, via the display. In some respects, this relationship can be 
understood by the transitive property: if a = b and b = c, then a = c. In other words, if 
the Ecology is accurately represented in the Sign (i.e., the display), the observer’s 
Concept should be reflective of the Ecology. Thus, an ecological display is one that 
has a strong semantic mapping. 
2.4. Understanding the Domain 
If the fundamental principle of ecological interface design is semantic mapping, 
then researching the domain is requisite in order for a designer to create an 
ecological interface that will have a strong semantic mapping. The display must be 
representative of the complexities within the domain to avoid trivializing the 
domain ecology. The next chapter will describe the laws and constraints of the 
detection, evaluation, and treatment (DET) of cardiovascular disease (CVD) in order 
to describe the ecology.
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3. THE ECOLOGY OF CARDIOVASCULAR RISK 
“Essentially, all models are wrong, but some are useful.” 
--George Box (1987; p 424)
3.1. Cardiovascular Disease 
Cardiovascular disease (CVD) is an umbrella term for diseases related to the 
heart and vasculature (Mendis, Puska, & Norrving, 2011). Some examples of 
common cardiovascular diseases include coronary heart disease (CHD), myocardial 
infarction, coronary insufficiency, angina, ischemic stroke, hemorrhagic stroke, 
transient ischemic attack, peripheral artery disease, intermittent claudication, heart 
failure, ischemic heart disease, coronary artery disease, and cerebral vascular 
disease (also abbreviated to CVD).  
There are many factors that contribute to cardiovascular disease. These 
include biochemical factors, sometimes referred to as clinical indicators (e.g., c-
reactive protein, high density lipoproteins [HDL], low density lipoproteins [LDL]), 
hemodynamics (e.g., systolic blood pressure), hereditary factors (e.g., family history 
of CVD), and personal lifestyle factors (e.g., eating habits, alcohol/tobacco use, Body 
Mass Index [BMI]).   
The list of risk factors is much longer than what we have just identified here, 
but when designing a visual display to aid medical decision-making, there is a 
question of how many risk factors must be accounted for to make adequate 
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decisions about diagnosis and treatment.  Designers must make a decision about 
how much data will be represented and how integrated that data will be. For 
instance, if values for every single risk factor for cardiovascular risk were presented 
in a display, it could easily overwhelm the user (and be prohibitively expensive to 
obtain via laboratory tests). On the other hand, integrating all the data into a single 
easy-to-read piece of information (e.g., healthy/unhealthy) could mean that domain 
has been oversimplified to the point that the user will fail when dealing with 
abnormal cases. Mathematical models are one way of accomplishing the reduction 
in the system’s complexity by focusing on the risk factors that are the most 
informative. Having a model to work from seemed like an excellent place to begin to 
understand the domain and became our entry point into the creative process.   
3.2. Cardiovascular Disease Risk 
3.2.1. Risk Types and Studies 
There are two main classes of risk used in the medical literature, both of 
which are products of their respective research methods and analysis techniques. 
The first type is relative risk which is the probability of 
contracting/developing/experiencing some health related event relative to 
exposure. The outcome of a relative risk study is a ratio of the probability of the 
event occurring in the exposed sample to that of a control sample.  For example, a 
relative risk study might produce a quantitative estimation of how much more likely 
smokers are likely to develop CVD than non-smokers.  
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The benefit of these types of studies is that they are, relatively speaking, easy 
to conduct. However, the down side is that the risk factors identified from relative 
risk studies do not lend themselves to integration with more sophisticated risk 
models. Without these more sophisticated and comprehensive studies that can 
simultaneously account for multiple factors and their interactions, it is difficult to 
know how multiple factors might work in concert with each other to influence risk. 
Fortunately, a number of these more sophisticated studies, large-scale 
epidemiological studies with thousands of participants providing information on 
many factors over the course of years and decades, have been conducted.  
The second class of risk is absolute risk or the absolute percentage of risk for 
experiencing an event given certain parameters. In the domain of CVD risk, one of 
the most accepted and used definitions of general cardiovascular risk is the 
probability of experiencing a cardiovascular event within the next 10-years 
(D’Agostino, Vasan, Pencina, et al., 2008; Ridker, et al., 2007, 2008).  The benefit of 
using absolute risk is that the models used to derive risk from the various risk 
factors can be used to reduce some of the system’s complexity and provide a 
framework for understanding the domain. 
Some of the epidemiological studies that have led to models of absolute risk 
for CVD include the Prospective Cardiovascular Münster Heart Study with German 
citizens (PROCAM; Assmann, Cullen, & Schulte, 2002), CUORE project with Italians 
(Ferrario, Chiodini, Chambless, Cesana, Vanuzzo, Sega, et al., 2005), the Beijing 
Cohort (Zhang, Attia, D’Este, Yu, & Wu, 2005), and the World Health Organization’s 
MONICA project (multinational monitoring of trends and determinants in 
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cardiovascular disease) which included 38 populations from 21 countries (Evans, 
Tolonene, Hense, Ferrario, Sans & Kuulasmaa, 2001).  Although each study differs 
from the others (and therefore leading to different CVD risk models), many risk 
factors are shared across models (see Table 1). As could be guessed, having multiple 
models is an indication of disagreement of which model is more accurate, and by 
extension, which risk factors to use.  
 
Table 1  Top CVD Risk Factors as Identified in Six Epidemiological Studies 
 Research Study/Model 
 FHS Reynolds Beijing MONICA CUORE PROCAM 
Age X X X  X X 
Total Cholesterol (TC) X X X X X  
Low-density lipoprotein (LDL)      X 
High-density lipoprotein (HDL) X X   X X 
Triglycerides       X 
Systolic Blood Pressure (SBP) X X X X  X 
Diabetes Mellitus (DM) X    X X 
Antihypertensive Medication Use X    X  
Smoker X X X X X X 
Body Mass Index (BMI) *  X X   
Hemoglobin A1c (HBA1c)  (If DM)†     
Family CVD History (FHx)  X   X X 
High Sensitivity C-Reactive Protein (hsCRP)  X     
Note. * BMI replaces the biochemistry levels in a simplified Framingham Risk Model  
† The initial all-female cohort used HBA1c as a covariate, but the all-male cohort did not. HBA1c has been subsequently 
removed from the risk calculation for both men and women. 
 
3.2.2. Disease Risk Models 
In the United States, there are two main competing risk models for CVD. The 
first model, the Framingham risk model, is derived from the Framingham Heart 
Study (D’Agostino, Ramachandran, Pencina, Wolf, Cobain, Massaro, et al., 2008), 
which has led to more than 1200 research articles (Framingham Heart Study, 2011) 
and is one of the most widely cited epidemiological studies. The Framingham risk 
model is commonly used as a comparison for other epidemiological studies and risk 
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models (Hense, Schulte, Lowel, et al., 2003; Brindle, Emberson, Lampe, et al., 2003; 
Zhang, Attia, D’Este, Yu, & Wu, 2005).  
However, the competing Reynolds risk model has demonstrated that it can more 
accurately classify patients into respective risk categories (e.g., <10%, 10-20%, 
>20% risk) than the Framingham model. The differences in reclassification are not 
trivial or mildly incremental; some patients would be reclassified to highest risk in 
the Reynolds risk model from lowest risk in the Framingham risk model and vice 
versa.  The reclassification would have a tremendous impact on treatment.  
In spite of the apparent superiority of the Reynolds risk model over the 
Framingham risk model, there are two factors against using it as a model for our 
graphical display. First, the Framingham risk model only requires the information 
obtained through the commonly ordered lipid panel test whereas the Reynolds risk 
model requires the high sensitivity c-reactive protein (CRP) level in addition to the 
lipid panel. The fact that a second test must be ordered in order to use this model 
makes it more difficult and expensive to implement in a clinical setting.  However, 
the primary reason for not using the Reynolds risk model is that the Framingham 
risk model has found greater acceptance among experts, including its adoption for 
use in the Third Report of the Expert Panel on Detection, Evaluation, and Treatment 
of High Blood Cholesterol in Adults (Adult Treatment Panel-III or ATP-III; National 
Heart, Lung, and Blood Institute, 2001).  
The ATP-III report and guidelines have been based on a review of over 1100 
scientific sources by leading experts in the field of cholesterol management/CVD 
risk and is sponsored by the National Heart Lung and Blood Institute (NHLBI; part 
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of the US Department of Health and Human Services [DHHS] and US National 
Institute of Health[NIH]). This report has established a number of guidelines for the 
treatment of hyperlipidemia. Given the preference by experts for the Framingham 
risk model and due to its incorporation into the ATP-III, it would seem to be a better 
source for understanding the domain until additional medical research can establish 
a different model that is clearly superior and has broader consensus.  
3.3. Mapping the Ecology to the Display: Creating the Graphical 
Display Elements 
3.3.1. The Framingham Risk Model and its Representation 
By adopting the Framingham risk model as the model for the basis for our 
work, the factors that we must consider are patient sex, age, total cholesterol level, 
high-density lipoprotein level, systolic blood pressure, whether the patient is taking 
medication for controlling their blood pressure, smoking status, and whether the 
patient has diabetes mellitus. However, simply knowing which factors are relevant 
does not constitute a useful risk model. 
What exactly is the Framingham risk model? The general cardiovascular risk 
model, as calculated from the Framingham risk model, is a mathematical model that 
is based on the Cox proportional hazards model (Cox, 1972), which is a multiple 
regression technique. This model is typically used in the healthcare domain for 
calculating expectancies of contracting, developing, or experiencing various 
healthcare problems or mortality within a specified window of time (usually 10 
years for CVD risk models). The Framingham risk model is noted as: 
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Figure 6 The Cox Proportional Hazards Model 
In Figure 6, the probability of experiencing a cardiovascular event within a 
certain time frame (e.g., 10 years) is noted as  ̂. The baseline survival rate, or 
percent of those who have not experienced a CVD event within 10 years, is denoted 
as s0(10). The variable X represents the individual’s score on some risk factor I and 
 ̅ is the population mean for risk factor i. The  s are the regression coefficients 
associated with each of the risk factors (see Table 2). 
Table 2  Framingham Risk Model Correlation Coefficients, Baseline Survival Rates, 
and Summed Means 
   β 




Natural Log of:   







SBP (if not 
treated) 
1.933 2.761 
SBP if treated 1.999 2.823 
Smoking 0.655 0.529 
Diabetes 0.574 0.692 
 Baseline Survival  
S0(t) 0.88936 0.95012 
Summed Means   
∑β ̅ 23.9802 26.1931 
 
In that both the baseline survival rate and e are constants, the primary 
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Figure 7 The Difference Score from the Cox Model 
Risk is based on the difference between the sum of an individual’s scores (multiplied 
by associated regression coefficients) and the sum of the mean scores (also 
multiplied by the respective coefficients). If there is no difference between these 
two summed products, then the sum of the product containing the observed values 
is equal to the sum of the product containing the population means. In other words, 
the difference score represents how different an individual is from the population 
mean in terms of risk.  
3.3.1.1. A Note on Language. 
The language of risk and risk factors can be hard to follow, so care must be 
taken when reading and thinking about them. For instance, if a patient is unhealthy, 
they will have a difference score that is positive. Usually, the word positive carries a 
good connotation, but this is not the case. When a difference is positive, it is 
negative, or detrimental, in the sense that it means that the patient has a higher than 
average risk score. A negative difference is positive, or beneficial, in that it means 
the patient has a good risk score.  
Also relevant to this discussion on language is with the term risk factor. 
Colloquially, risk factor carries a connotation of bad or something that increases 
risk. However, a risk factor, as used in this document, refers to any factor that was 
included in the ATP-III model, regardless of whether it has a negative or positive 
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regression coefficient. Consider that HDL has a negative regression coefficient (see 
Table 2), which one might expect to reduce risk. However, this is not always the 
case. Sometimes the risk factors that one might consider to be detrimental or 
beneficial have the opposite effect. The reason becomes more clear when Figure 7 is 
rewritten as:  
∑(  
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Figure 8 Rearranged Difference Score from the Cox Model 
Although the sum of the differences of X and  ̅ (multiplied by their respective 
coefficients) is mathematically equivalent to the difference between the sum of all 
Xs and sum of all  ̅s (also multiplied by their respective coefficients), Figure 8 
allows one to calculate the unique contribution of each factor in the risk model. Due 
to the fact that this expression is a comparison between an observed value from the 
patient and the population mean, how much a risk factor influences risk is a function 
of whether the observed value is greater than or less than its respective mean. With 
this information, a contribution graph can be constructed to illustrate which factors 
are the primary drivers of risk for a particular patient, which is the main purpose for 
rewriting the Figure 7 expression in this manner. The benefit of determining the 
unique contributions is that physicians can now be provided with a means of 
quantitatively evaluating the severity of each risk factor in order to better support 




Table 3  Values for Labs and Vitals of a Hypothetical Patient 
Risk Factor Value 
Sex Male 
Age 52 
Total Cholesterol (TC) 254 
HDL Cholesterol (HDL) 36 
LDL Cholesterol (LDL) 173 
Triglycerides 228 
Takes BP Meds? No 
Systolic Blood Pressure 
(SBP) 
138 




Diabetes Mellitus (DM No 
CVD Risk 10% 
 
Consider the patient in Table 3. The extent to which each factor influences 
risk is not immediately clear. For example, which risk factor is the most important to 
address first? Does that risk factor increase 10-year risk the most? Is it worse to 
have total cholesterol at 254 mg/dL, an LDL cholesterol level of 173 mg/dL, or a 
systolic blood pressure of 138? We believed that our graphical representation of the 




Figure 9 Graphical Representations of the Framingham Risk Model and Contribution Bar Chart 
3.3.2. Graphical Representation of the Framingham Risk Model 
The graphical representation for the Framingham risk model consists of two 
major components (see Figure 9). The bottom half of Figure 9 is a contribution bar 
graph based on the differences in observed scores from their respective means as 
described earlier in Figure 8 (i.e., their unique contribution).  The x-axis (ranging 
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from -2.0 to 3.5 demarcated in increments of 0.5 units) is shared between the top 
and bottom halves of this graph. This number line represents the range of possible 
difference scores as calculated from the expression in Figure 8. There are two 
contribution bars in the display. The bottom bar represents the (summed) 
contribution of all risk factors that increase 10-year risk, while the top bar 
represents the (summed) contribution of all risk factors that decrease 10-year risk 
for the patient. Arrows serve to guide to the direction to which the bar is extending. 
In Figure 9, age, total cholesterol, HDL, and systolic blood pressure increase risk 
while smoking status decreases it. 
Due to biological range restrictions (e.g., no person will have a blood 
pressure of 500 mmHg or a total serum cholesterol level of 0) and to the fact that 
continuous variables (i.e., everything but smoking status and whether the patient is 
a diabetic) have been transformed using the natural log, the difference of the sum of 
weighted patient scores and the sum of weighted population means will rarely be 
more than 3.5 or less than -2. These values set the range of the graph’s horizontal 
axes.  
 The top half of Figure 9 contains a graphical representation of the Cox 
proportional hazard function that has been aligned to the Framingham model 
parameters. The y-axis of the Cartesian plane is divided into three areas using three 
colors. The coloring scheme follows the traditional convention of green, yellow, and 
red to indicate good, warning, and bad, respectively. More specifically, these areas 
and colors map onto a treatment options matrix (derived from the ATP-III 
guidelines) that will be discussed shortly. For now, it should be sufficient to say that 
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the risk levels used for the treatment option table are broken into three categories 
of risk: less than 10% (green), 10-20% (yellow), and grater than 20% (red). The 
patient’s 10-year risk value is plotted along the curve as a function of the difference 
score mentioned earlier in Figure 8. We have drawn a line from the difference point, 
to the curve, and to the patient’s risk score. We also project a horizontal line from 
this point that reaches beyond this component to the treatment option matrix.  
The purpose of an ecological or semantically mapped graph is to tie the 
domain to the display, so that the domain is more transparent to the observer. This 
graph has attempted to achieve this goal by showing how much each factor 
contributes to the patient’s risk. Additionally, it demonstrates that risk is a 
curvilinear function, which explains in part why sometimes risk factors with large 
regression coefficients may only raise the patient’s risk a trivial amount. By now, it 
is hoped that the concept of mapping graphical features to the domain should be 
clear to the reader. Now that a model allowing for the calculation of risk based on a 
number of risk factors has been represented graphically, the next step is to map 
them to the diagnosis and treatment process. The next section will focus on this 
mapping between the model and the treatment options for both cholesterol and 
blood pressure.  
3.3.3. Treatment Options and their Representations 
3.3.3.1. Treatment Options 
This research is aimed at developing an aid for physicians and patients to 
gain a better understanding of a patient’s CVD risk and allow them to make 
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treatment decisions that use the guidelines as a basis. In treating a patient at risk for 
CVD, each risk factor is important to address. We have chosen to address two of 
these components in our display. The first is hyperlipidemia, or elevated lipid levels, 
as a way of preventing atherosclerosis (a precondition of CVD). Hypertension is the 
other component that we focused on, primarily due to its prevalence and convenient 
access to relevant data. Obtaining a blood pressure from a patient is a standard part 
of providing care, and given that it is a required part of the Framingham risk model, 
there would always be blood pressure data available without the expense of 
additional lab tests (as in the case of the c-reactive protein).  
We have already briefly mentioned the ATP-III guidelines for treating 
hyperlipidemia. Hypertension also has its own set of treatment guidelines as put 
forth in the Seventh Report on the Joint National Committee on Prevention, 
Detection, Evaluations, and Treatment of High Blood Pressure (JNC-7; Chobanion et 
al., 2003). Both the ATP-III and JNC-7 guidelines from these reports create 
constraints in the detection, evaluation, and treatment (DET) processes for 
physicians. As constraints, these guidelines are important to incorporate into a 
graphical display intended to aid providers in the DET process.  
The ATP-III Treatment Options Matrix. 
Although, the ATP-III explicitly states that it should not be considered a 
standard of care (p I-2), it is likely the most comprehensive document on the topic 
and is referenced frequently in the literature. As such, the ATP-III guidelines serve 




The relationship between hyperlipidemia, atherosclerosis, and CVD stresses 
the importance of the use of the lipid panel to screen for abnormal values in order to 
treat dyslipidemia as the primary means of preventing CVD. Accordingly, the ATP-III 
guidelines give LDL cholesterol the preeminent position in the treatment process, 
where it is the primary target for reduction.  
Curiously enough, it should be recalled that LDL is not included in the 
Framingham risk model as a risk factor (although it is counted indirectly in obtained 
“Total Cholesterol” value), in spite of its role in the treatment process. According to 
the ATP-III guidelines, LDL is the primary target for cholesterol reduction for 
treating hyperlipidemia. The second factor used to determine treatment for 
hyperlipidemia is the 10-year risk as calculated from the Framingham risk model.  
The ATP-III guidelines suggest treatments for the various combinations of LDL and 
10-year Risk levels. The treatment options include Therapeutic Lifestyle Changes 
(TLC; such as avoiding certain foods and increasing physical activity), as well as the 
Drug Therapy (DT) treatment option. No Treatment (NT) is a third option if the 
patient is healthy enough. These guidelines can be seen in Table 4. We have taken 
these guidelines and created a graphical interpretation, which we call the treatment 









The purpose of the TOM is to help the viewer visualize the treatment option 
space. The red area represents the space where DT is recommended by the ATP-III 
guidelines, while the yellow area represent the TLC recommendation. The green 
area represents the NT space. This display contains a very explicit mapping from the 
guideline data to the treatment options. Finding the recommended treatment in the 
TOM is a matter of plotting a point using a two-dimensional Cartesian coordinate 
system, where LDL level and 10-year risk are the respective abscissa and ordinate. 
When the TOM is integrated fully into the ecological display, we include visible lines 
that project from the axes to meet at the specified coordinates. 
Table 4  ATP-III Treatment Guidelines 
Risk Category LDL Goal LDL level to initiate 
Therapeutic Lifestyle 
Change (TLC) 
LDL level to initiate 
Drug Therapy (DT) 
CHD or CHD Risk 
equivalent 
<100 mg/dL  100 mg/dL  130 mg/dL 
2+ Risk Factors <130 mg/dL  130 mg/dL 10-year risk 10-
20%: 
 130 mg/dL  
10-year risk <10%: 
 160 mg/dL 
0-1 Risk Factor <160 mg/dL  160 mg/dL  190 mg/dL 
(160-189 mg/dL: 





Figure 10 The Treatment Option Matrix 
The JNC-7 Bar Graph. 
The Seventh Report on the Joint National Committee on Prevention, 
Detection, Evaluations, and Treatment of High Blood Pressure provides guidelines 
for treating hypertension. However, these guidelines are much simpler than the 
multidimensional guidelines used in the ATP-III for cholesterol. The JNC-7 
guidelines consider hypertension a condition of either elevated systolic or diastolic 
blood pressure (SBP and DBP respectively). The specific guidelines for classification 
can be found in Table 5. 
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Table 5  Blood Pressure Classifications and Recommended Treatments (JNC-7) 
BP Classification SBP (mmHg) DBP (mmHg) Treatment 
Normal <120 and <80 NT 
Prehypertension 120-139 or 80-89 TLC 
Stage 1 Hypertension 140-159 or 90-99 DT 
Stage 2 Hypertension ≥ 160 or ≥ 100 DT 
 
The information contained in Table 5 lends itself easily to the creation of two 
number lines in an ecological display for systolic and diastolic blood pressure 
respectively. A number-line/bar-graph hybrid (known simply as the JNC-7 bar 
graph) was created for representing blood pressure and can be seen in Figure 11.  
Treatment for elevated blood pressure is somewhat similar to that of 
hyperlipidemia in that treatment options are comprised of NT, TLC, and DT. The 
green area (labeled “good”) in Figure 11 has the recommendation of NT. The yellow 
area (labeled “pre” for pre-hypertension) has the recommendation of TLC. The areas 
labeled “Stage 1” and “Stage 2” (the orange and red areas respectively) refer to 
degrees of hypertension and both have the recommendation of DT. It is 
recommended that although both should be considered with DT, those in Stage 1 
should begin their DT regimen with a single blood pressure reducing drug, while 









3.4. Mapping the Ecology to the Display: Assembling the 
Graphical Elements 
 We hired a software developer to help us create a prototype of the ecological 
display. This prototype included the Framingham model and contribution bar chart, 
the TOM, and the JNC-7 bar graph. We also added a number line display (see Figure 
12) as a means to enter and change patient data in the system (we did not have a 
real database of patient data to draw upon).  
 The number line format consisted of number line representations of some 
continuous data (e.g., age, total cholesterol, etc.) as well as some dichotomous 
variables such as whether the patient had an existing heart disease or equivalent 
(ExstHD). Some variables are dichotomous by nature (e.g., Is there a family history 
of CHD?; FamHx). Others were (or could have been) continuous variables that were 
treated dichotomously by the model (e.g., was the waist circumference greater than 
40 inches [>40in] or fasting blood glucose greater than 110mg/dL [>110mg]). These 
dichotomous variables were created as sliding buttons, such that the white portion 
of the button indicated the selection (e.g., a white box surrounding the “N” indicates 
that the patient does not meet the criteria).  
 The color disruptions along each number line correspond to different 
severity categorizations for each respective risk factor. The boundary for the factor 
“Age” at 45 does not come from any published research, but is simply the point at 
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which age begins to have a detrimental effect on 10-year risk according to the 
Framingham risk model.  
 The blue-ish box in the top left corner of Figure 12 is a button intended to 
switch between male and female models (M/F), but this functionality was not 
complete at the time of the study and was therefore ignored. The implication for this 
was that all of our stimuli were males.  
 The colored boxes and arrows for some of the risk factors correspond to the 
colors used for risk factors elsewhere in the ecological display. The colors serve as a 
sort of legend for distinguishing among the various risk factors. For instance, the 
dark brown color of diabetes in the number line interface is the same as the color 
used to denote the unique contribution of diabetes in the contribution bar chart.  
 When all of the graphical components come together, they form the entire 
ecological display (see Figure 13). This display is what we evaluated in this 
research. 
3.5. Summary 
 This chapter has laid the foundation for understanding the work Ecology of 
detecting, evaluating, and treating cardiovascular risk and associated diseases. The 
Framingham risk model provides a list of important risk factors necessary to 
determine the 10-year risk of experiencing a cardiovascular event for a patient. This 
model also allows the unique contribution of each risk factor to be calculated, 
allowing for comparisons about their influence, which in turn, can guide treatment 
decisions. The ATP-III treatment model allows 10-year risk to be combined with 
LDL cholesterol level in order to arrive at the recommended treatment for 
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hyperlipidemia. The JNC-7 treatment model accomplishes the same, but for 
hypertension. We have attempted to illustrate Meaning by mapping the Ecology to a 
graphical representation in order to aid physicians and patients to understand this 









Figure 13 The Ecological Display 
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4. STATIC DISPLAY EVALUATION 
“If we knew what we were doing it wouldn’t be [called] research.” 
--Attributed to Albert Einstein
4.1. Research Overview 
4.1.1. Research Plan and Goals 
In order to evaluate the ecological display, we decided that the basic research 
method would entail having participants complete four tasks under what we call the 
detection, evaluation, and treatment (DET) framework, which was modeled after the 
implied workflow processes in the ATP-III and JNC-7 guidelines (NHLBI, 2001; 
Chobanion, 2003). The tasks under the DET framework would require participants 
to view the data from a number of patient cases in one of multiple display formats 
and then make decisions and judgments regarding the presence, risk, and treatment 
of hyperlipidemia and hypertension.  
These four tasks were: (1) the concern task to measure participants’ concern 
level for each patient case, (2) the follow-up task to identify differences in which 
risk factors were perceived to require follow-up due to display format, (3) the 
treatment decision task to examine whether the display format would lead 
participants to select treatment options that were more likely to agree with ATP-III 
and JNC-7 guidelines, and (4) the ranking task to determine if display types were to 
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allow participants to more accurately identify the risk factors that increase 10-year 
CVD risk the most.  
4.2. Method 
After discussion with some medically trained advisors, we were informed 
that these tasks would be too difficult for non-medically trained participants. They 
also informed us that it would take about 6 minutes for participants to complete all 
four tasks for each patient case and that we were likely to only get about an hour of 
participation time from each participant. These constraints limited the number of 
cases we could evaluate. However, some of these advisors were associated with an 
internal medicine residency program at a local urban hospital and invited us to 
conduct our research with their residents during one of their weekly training 
seminars. This provided us the opportunity to collect data from more than 20 
medically trained participants over the course of a few hours rather than a single 
hour.  
4.2.1. Participants 
Twenty-three residents participated in the study. The mean age was 29.75 
years (SD = 4.22 years, age range: 25 – 40 years). Twenty-one residents provided us 
with information regarding their gender. Of those that responded, 57% (12) 
indicated that they were female. Thirty-nine percent of participants self-identified 
race as “White,” 13% as “African American,” 34% as “Asian,” 4% as “Other,” and 
10% did not respond. None identified as Hispanic or Latino. The mean year in 
residency was 2.19 years (SD = 0.8) of a 3-year program.  
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Residents were verbally informed by the researchers, as well as their residency 
program director, that they would not be required to participate in the study and 
that their individual results would not be shared with hospital faculty. However, the 
program director did encourage the residents to follow along as part of their 
educational experience, even if they did not want to submit their responses for 
research. All residents were provided with the opportunity to enter a drawing for an 
iPad® as a matter of goodwill and as a way to encourage participation in the study 
(although participation was not a condition of eligibility for the drawing). All 
residents entered the drawing for the iPad and all consented to include their results 
in our research study. 
4.2.2. Materials 
4.2.2.1. Stimulus Packets 
Upon entrance to the seminar room, participants were handed an informed 
consent form and two packets of 8.5” × 11” inch white paper. The residents were 
instructed to review and sign the consent form if they wished to participate in the 
study and were further instructed not to look at either packet until given further 
notice. The first packet contained the stimulus materials containing the patient 
cases and the other packet contained the corresponding response forms.   
 Given our time constraint, we estimated that we would have time for twelve 
male patient cases. One half of the cases had data presented in the number line 
format while the other half contained data presented in the ecological display 
(which also included the number line format). All stimuli packets contained the 
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same 12 cases. The displays were all printed in color. All cases were male due to the 
fact that the software used to generate the cases only worked for males at the time.  
The stimulus presentation order had been randomized prior to administration in 
order to reduce the probability of patient pairs (to be discussed shortly) appearing 
sequentially. All packets presented cases in the same order.  
Patient Pairs. 
Given our intention to compare performance of different display types, and 
given the relatively few cases and participants, we opted for a repeated measures 
design. To reduce the potential of participants recognizing the case in the second 
condition, we created the twelve cases so that each had another similar case in the 
opposite condition. Each pair was matched in some respects but differed in others 
(see Table 6). This meant that we altered many of the risk factors of one patient a 
few points above or below its counterpart. Thus, no patient was exactly the same as 
another, but was similar enough to one another to allow for some comparisons.  
The primary factor to which we tried to match cases was the manner in which they 
should be treated according to the medical guidelines. For example, Patients 1 and 2 
were not exactly the same age nor did they have the same systolic blood pressure, 
but both would likely require drug therapy according to the ATP-III guidelines for 
treating hyperlipidemia. Pair 3 was the exception to this rule and had different 









LDL SBP DBP Context/Rationale 
1 Med DT DT TLC Patient could quit smoking to drop to NT for 
cholesterol 
 
2 Low NT TLC TLC Patient had enough risk factors to have 
metabolic syndrome 
 
3 Low TLC NT/TLC TLC Although patient has low LDL cholesterol that 
would not normally require treatment, their 
diabetes places them into the high risk area 
and requires TLC 
 
4 Low DT DT TLC Patient has many treatment modifying risk 
factors that suggest TLC for cholesterol instead 
of NT if fewer factors were present 
 
5 Med DT DT DT Patient with relatively good cholesterol levels, 
yet requires DT 
 
6 High TLC TLC TLC Patient whose risk is mostly determined by 
age 
 
Note. In Pair 3, the treatment for SBP in the ecological condition is NT and TLC in the number line 
condition.   
Response Forms. 
  The packet of response forms was 13 pages long—twelve pages for recording 
responses for each case and one final page for collecting demographic data. An 
additional space for notes was provided if3 residents felt that certain decisions 
needed clarification or justification. A copy of this form may be found in Appendix A. 
The next section will provide further details into these tasks and the measures used. 
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4.2.2.2. Performance Evaluation and Measures 
Accuracy vs. Guideline Agreement. 
Before we discuss the specific tasks from the response forms and 
performance measurement, we need to make a distinction between accuracy and 
guideline agreement. Accuracy is a loaded word—it carries a connotation of a 
comparison between a response to some objective answer or standard. We did not 
always have the benefit of a standard or guideline in this research. There were some 
cases where even though there were standards, there was some flexibility in them. 
For instance, one physician reported that they were completely confident in the 
medical decision that they were making for the patient, yet were fairly certain that 
their decision did not follow the ATP-III and JNC-7 guidelines and that the guideline 
was wrong for that specific patient.  
Although it might be tempting to say that this physician was wrong and that 
the guidelines should be considered to be the objectively correct answer, it should 
be noted that both the ATP-III and JNC-7 guidelines both defer to the physician’s 
clinical judgment in all cases. Thus, instead of using the term accuracy to refer to the 
extent to which a participant followed the guidelines and possibly give the false 
impression that one graphical display allows one to make more “accurate” decisions, 
we will use the term, guideline agreement, to indicate that one display might be able 
to lead one to make decisions that are more likely to agree with the established 
guidelines. The difference is subtle, yet extremely important.   
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4.2.2.3. The Tasks 
Concern Task. 
There are many CVD risk factors that can be combined to create high 10-year 
risk, including cases where many factors appear to be relatively normal. This might 
lead to a sense that the patient is healthier than they might otherwise be. We 
wondered if the graphical presentation format of data might influence the 
impression of a patient’s health and increase or decrease a physician’s sense of 
concern for that patient.  
The level of concern was recorded by having the participants indicate their 
concern on a 4-point scale found at the top of the response form. The possible 
answers were: (1) “Not concerned at all, seems to be in good health” (2) “A little 
concerned, there is some risk present” (3) “Quite concerned, there are several 
worrisome findings,” or (4) “Very concerned, there are significant worrisome 
findings.”  
We did not have any specific hypotheses to test, but given the various risk 
levels and treatments that were recommended, we estimated that there would be 
some ordering to the concern expressed (see Table 7). 
 
Table 7 Expected Concern across Patient Pairs  
Concern Patient Pair 
Greatest 1, 5 
Middle 4, 6 





 The follow-up task required the resident to review a list of risk factors and 
indicate in a check box whether they felt that the particular risk factor should 
require some follow-up. The follow-up response was strictly dichotomous—either 
the factor was felt to require follow-up or not. Although there could have been many 
degrees of concern for any of the risk factors, we wanted to use a dichotomy as a 
means to find the “obvious” differences. This list of items to be considered included: 
total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, systolic blood 
pressure, diastolic blood pressure, diabetes, smoking, obesity, blood sugar, and 
metabolic syndrome.  
 With this task, we evaluated the agreement within residents’ responses for 
follow-up for each risk factor when using the two graphical displays. We compared 
the responses for each participant and tallied the number of times that the 
responses across both conditions differed using a sign test or binomial test 
paradigm. For instance, if a participant chose to follow-up on a risk factor in one 
graphical condition and not in the other, a tally mark would be made for the 
corresponding graphical condition. If the responses were similar across both 
conditions (either both indicated or not), no tally mark was made. The sum of tally 
marks across all participants was an indication of the agreement between the 
graphical conditions.  A high tally is an indication of low agreement between the 
graphical displays and suggests that one display format leads to differences in the 
frequency at which participants endorse follow-up.  
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  With the exception of believing that there would be low agreement for 
follow-up on metabolic syndrome in patient pair 3 (the only cases which met the 
metabolic syndrome criteria) due to the pentagonal shape for metabolic syndrome 
in the ecological display, we did not have a logical means for determining which 
factors or graphical format would lead to any potential differences.  
Treatment Decision Task. 
 We were interested in determining how residents would choose to treat the 
various risk factors associated with blood pressure and cholesterol. For this task, 
participants were given a matrix of risk factors and treatment decisions on the 
response form and were asked to indicate how they would choose to treat each risk 
factor by checking the corresponding box. The risk factors included: total 
cholesterol, LDL, HDL, triglycerides, SBP, DBP, smoking, diabetes, obesity, and blood 
sugar. The treatment options were: no treatment (NT), therapeutic lifestyle changes 
(TLC), and drug therapy (DT). 
 Although we asked about treatment decisions for many risk factors, we only 
focused on the treatment decisions for LDL cholesterol, SBP, and DBP because they 
were the only factors for which we had specific treatment guidelines.  As with the 
follow-up task, we were measuring agreement. Guideline agreement was measured 
similarly as before, but responses within each graphical condition were first 
compared to the respective guidelines before being compared to the corresponding 
graphical condition. For example, if a resident chose an answer that did not agree 
with the guideline when using the number line but chose the answer that agreed 
with the guideline when using the ecological display, a tally mark was awarded to 
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the ecological display condition. Low agreement between the graphical conditions 
indicates that residents chose a particular treatment more frequently in one 
condition than the other and that the response was in agreement with the 
corresponding guideline. In other words, one graphical condition had greater 
guideline agreement. 
 Given the fact that we created the ecological display to help users to visually 
make the connection between the data and the guidelines, we hypothesized that the 
ecological display condition would lead to greater guideline agreement for LDL, SBP, 
and SBP.  
Ranking Task. 
 One difficulty of an alphanumeric table or number line is that it is difficult to 
tell which risk factor has the greatest influence on a patient’s risk or, in other words, 
which is the most important to treat. The six factors identified in the Framingham 
model (i.e., total cholesterol, HDL, systolic blood pressure, age, and smoking status) 
were presented for each patient on the response form.  The residents were asked to 
rank the risk factors for that specific patient case in terms of their severity as 
specified by the product of the risk factor level and its regression coefficient from 
the Framingham model.  
 Given the many risk factors that influence risk, we were interested in not 
only whether residents were able to more accurately identify the top risk factor but 
whether they could identify the top two and top three risk factors as well, regardless 
of order. The rationale was that a physician might be able to identify the top risk 
factors, but not necessarily in the precise order.  
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The top two and top three risk factor components were scored such that the 
precise order was irrelevant as long as the factors were included in the grouping. 
For example, if the top three risk factors were HDL, LDL, and Age and a resident 
ranked them as HDL, Age, and LDL, they would have correctly identified the top risk 
factor, but not the top two risk factors. However, the resident would still have 
correctly identified the top three risk factors. In theory, the task gets easier as more 
factors are added because the list of factors grows and order becomes less 
important. 
We believed that because the ecological display provides the unique 
contribution of each factor in the display (i.e., the contribution bar chart), we 
hypothesized we would find that more residents would correctly identify the top 
risk factors when using the ecological display. For this measure, we simply used the 
count of participants who correctly identified the factors at each of the levels (i.e., 
the top, top two, and top three factors) rather than making agreement comparisons 
as with the other tasks.  
4.2.2.4. Procedure 
The study was conducted during the residents’ weekly seminar forum, which 
took place in a small auditorium-style classroom (seating capacity approximately 
40) of a local urban hospital.  After having been introduced by the resident program 
director, we used a PowerPoint presentation projected from an overhead projector 
to introduce the EID display to the participants and explained the task instructions 
by reading aloud from a script (see Appendix B). In the instructions, we asked the 
residents to work as quickly and accurately as possible, but noted that accuracy was 
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more important than finishing all cases. After the instructions, we allowed the 
residents additional time to review and sign the informed consent. Residents were 
also informed that they were free to leave at the conclusion of the study, but that we 
would have a presentation about ecological displays and data visualization at the 
conclusion of the study for those interested.  
Once all residents had indicated that they were ready to begin, we instructed 
them to turn over the stimuli and response packets and begin the study. The study 
was self-paced, with an upper limit of three hours for completion. All residents 
finished all cases within 1 hour and 45 minutes.  
4.3. Results 
4.3.1. Concern 
The distribution of concern levels for each case is located within the table 
found in Error! Reference source not found.. The mode of all concern levels for all 
cases was 2 (i.e., “A little concerned, there is some risk present”) with the exception 
of pair 5 (cases 9 & 10) which had a mode of 3 (i.e., “Quite concerned, there are 
several worrisome findings”). We believed that Pair 5 would be one of the Pairs with 
the highest levels of concern. This was the case, but we were surprised that Pair 5 
only had a mode of 3. In fact, all of the scores seemed to be lower than we thought, 
particularly in light of the fact that nearly all cases were designed to require 
treatment.  It would appear that with the exception of pair 5 having a mode of 3, 
there did not appear to be any meaningful differences in concern between display 





Figure 14 Expressed Concern Levels Across Patient Pairs 
4.3.2. Follow-Up 
Other than metabolic agreement for metabolic syndrome for pair 3, we did 
not have any specific hypotheses to test with the follow-up task; we were simply 
interested in determining whether participants responded differently between the 
display types.   
In the sign test paradigm, “successes” (x) are the number of times an event 
occurs in one condition but not in the other. In our case, a “success” represented the 
ECO NL ECO NL ECO NL ECO NL ECO NL ECO NL
Pair 1 Pair 2 Pair 3 Pair 4 Pair 5 Pair 6
Very Concerned 0 0 1 0 0 0 0 0 1 0 1 0
Quite Concerned 7 7 1 5 1 4 5 4 18 17 6 9
A Little 14 12 19 15 19 14 18 17 4 6 16 13









































Display condition by Patient Pair 
Concern Across Patient Pairs 
 
 58 
event of a resident having chosen to follow-up using only the ecological display. The 
number of trials (n) represents the number of events that resulted in a tie or where 
a resident chose to follow-up (or not) in both conditions. As the number of ties 
increase, the trial size shrinks for each comparison. If there are many “successes” or 
“failures” (i.e., where follow-up was indicated only with the number line), then there 
is little agreement between the two displays and one display is more likely to have 
been used to indicate follow-up.  
  We used a two-tailed sign test (assuming a probability of 0.5) to 
calculate the agreement between the two displays. The fraction-like numbers in 
Table 8 represent this relationship with the number of follow-up indications with 
only the ecological display (i.e., “successes”) on the left and number of trials the 
right of the slash.  The exact calculated probabilities are located beneath each 
fraction.  
Due to the many instances where n was low (e.g., less than 6) or where x was 
approximately half of n (e.g., 4/8), we only performed seven binomial tests. Of the 
seven tests, five proved to be significant. However, of the five significant differences, 
two for Pair 3 should be discounted because they reflect differences in the TC and 
Triglyceride levels between the associated cases (i.e., higher values in one format) 




Table 8  Ecological Display Follow-up Differences by Patient Pair 
Pair TC LDL HDL Trig SBP DBP DM Smk Obes BS MS 
1 
5/7 4/6 0/0 0/0 1/2 0/2 0/0 2/3 0/1 1/1 0/1 
-- -- -- -- -- -- -- -- -- -- -- 
            
2 
1/4 1/4 1/8 0/4 4/7 4/7 1/2 0/0 0/0 1/5 12/12 
-- -- 0.07 -- -- -- -- -- -- -- 0.0004** 
            
3 
8/9 1/1 0/1 9/10 0/2 0/2 0/2 1/2 1/2 0/0 1/4 
0.04* -- -- .02* -- -- -- -- -- -- -- 
            
4 
2/2 0/1 3/4 0/0 6/6 7/9 0/0 0/1 0/0 0/0 2/2 
-- -- -- -- .03* .18 -- -- -- -- -- 
            
5 
1/4 1/2 0/2 0/0 0/2 0/6 1/1 1/1 3/3 2/2 4/5 
-- -- -- -- -- .03* -- -- -- -- -- 
            
6 
4/7 5/7 2/3 1/2 4/6 4/6 0/1 0/1 2/3 3/4 1/2 
-- -- -- -- -- -- -- -- -- -- -- 
Note: The top row of each Pair is a pair of numbers divided by a slash; the number to the left 
is the number of “successes” (i.e., x) and the number to the right is the number of trials (i.e., 
n). The number on the bottom row for each pair is the probability of achieving x or more 
successes out of n trials. The slightly greyed exact probabilities are the values that cannot be 
explained by differences in the cases.  
  
There was low agreement for Pair 2 on HDL, where more residents chose to 
endorse follow-up while using the number line display, but this difference only 
approached significance (p = .07, two-tailed). However the primary finding for Pair 
2 is the low agreement for follow-up on metabolic syndrome, where residents were  
significantly more likely to only follow-up when using the ecological format (p = 
0.0004).  This is not surprising given that the ecological display makes a point to 
highlight this syndrome with red text and a pentagon shape while the number line 
does not share such features.  
 More residents chose to follow-up only on SBP using the ecological display 
for Pair 4 (p = .03), but we are unsure of the reason for this. More residents only 
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chose to follow-up on DBP using the number line display for Pair 5 (p = .03), but we 
are also unsure of the reason for this.  
Over all, performance was rather similar for follow-up between the display 
types. This similarity is reflected in low number of meaningful significant 
differences and in the fact that of the 66 potential tests (6 cases × 11 risk factors), 
there were only three instances where n was greater than 9. In other words, only 
about 5% of the comparisons had 9 or more participants chose different answers 
between graphical conditions. 
4.3.3. Guideline Agreement 
When reviewing the data, we noted that many participants chose to indicate 
both TLC and DT for some patients. Given the fact that the medical guidelines always 
recommend prescribing TLC along with DT, we coded these instances strictly as DT.  
We hypothesized that the ecological display would lead to greater agreement with 
the ATP-III and JNC-7 guidelines. We used a one-tailed binomial test (assuming a 
probability of 0.5) to test the difference between the number of cases where 
participants only chose to agree with the guidelines with the ecological display for 
each patient pair. Table 9 contains the results for each test. There were only six 
significant differences and all of them favored the ecological format. However, two 
of the significant differences (SBP and DBP for Pair 3) were an artifact of the 
different risk level values, rather than due to the display (i.e., the blood pressures 
were borderline for one condition and not the other). Twenty-two percent of all 
binomial tests resulted in support for our hypothesis that the ecological display 
would lead to greater guideline agreement.  
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Table 9  Guideline Agreement for the Ecological Display by 
Patient Pair 
 
LDL SBP DBP 
Pair k/n p(X ≥ k) k/n p(X ≥ k) k/n p(X ≥ k) 
1 10/12 0.02* 4/7 0.50 3/7 0.77 
2 7/8 0.04* 3/6 0.66 2/5 0.81 
3 4/7 0.5 14/14 0.001** 14/15 0.001** 
4 7/7 0.007** 3/5 0.5 4/7 0.5 
5 5/6 0.11 0/1 1 0/3 0.125 
6 4/6 0.35 6/6 0.02* 4/6 0.34 
4.3.4. Ranking 
 We created six graphs to examine any patterns that might have emerged in 
the ranking responses (see Figure 15, Figure 16, Figure 17, Figure 18, Figure 19, & 
Figure 20).  These graphs plot the number of residents who correctly identify the 
top one, top two, and top three risk factors that increase 10-year CVD risk for the 
corresponding patient case in each Pair. For instance, in Figure 15, twenty-one 
residents identified the top risk factor using the number line display and 18 
identified the top factor when using the ecological display. Fourteen residents then 
identified the top two risk factors (in any either order) and 15 identified the top 
three risk factors (in any order) when using the number line format. The implication 
of these results would suggest that the top risk factor was easy to identify using the 
number line display but the second and third risk factors were more difficult to 
identify.  
On the other hand, when using the ecological display, most residents 
identified the top risk factor (although fewer than when using the number line), but 
confused the second most detrimental risk factor with the third most detrimental 
 
 62 
risk factor. This is likely because it is easier to identify the top risk factors in general 
than it is to identify the specific order of those risk factors.   
 As a whole, these results provide insight into the difficulty of identifying the 
top risk factors regardless of display type. Only in two Pairs (1 & 3) did more than 
15 residents correctly identify the top risk factor. The other four Pairs tended to 
have identification rates less than 60% for identifying the top risk factor.  
Sometimes residents were able to identify the top (one-, two-, or three) risk 
factors more easily when using the ecological display and sometimes it was more 
difficult. We are not sure why these results are so conflicting, particularly in case of 
the ecological display, which provides users with a graphical means to evaluate the 
influence of each risk factor.  
 
 





















































































































Figure 18 Number of Correct Identifications by Number of Factors and Display Type for Patient Pair 
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Figure 20 Number of Correct Identifications by Number of Factors and Display Type for Patient Pair 
6 
4.4. Discussion 
With the exception of guideline agreement, our results were not what we had 
expected. We imagined that there would be greater levels of concern expressed for 
these patients than what was indicated, particularly in the cases of patients with 10-
year risk levels of 20% or more or those who should be on drug therapies for both 
hypertension and hyperlipidemia. Perhaps we needed a scale with a greater range 
to capture some of the nuances that we may not have been able to capture, such as 
possible interactions of risk levels and treatment options.  
 In terms of follow-up, although we had no formal hypotheses, it was no 
surprise to find that more residents endorsed follow-up on metabolic syndrome for 
Pair 3, particularly for the fact that the ecological display practically spells out this 
syndrome for the user and the number line does not. Given that Pair 3 was the only 
Pair that had cases with metabolic syndrome, we would like to try and replicate this 






































results might be spurious in the same way that we suspect that the other two 
significant differences might be, given that we do not have a ready explanation for 
them like we do for metabolic syndrome. Further research is certainly needed to 
determine if these are real or spurious differences and why they occur or not.   
 We also found support for the ecological display as a means to increase 
guideline agreement. Not every test proved to provide a significant difference 
between the two formats, but every significant difference supported the ecological 
display. 
 The ranking task results were also surprising in that so few residents could 
correctly identify the top risk factors in any order. Even with the contribution bar 
chart in the ecological display to provide the correct answers, many failed to identify 
the correct factors. The pattern of correct identifications was not even consistent 
among cases or Pairs. We are not sure what to make of these results and should be 
the subject of future research. 
 We believe that there are at least three factors that influenced the results. 
First, we believe that our participants may not have had enough training or 
familiarity to take advantage of or trust the ecological display. Given the fact that 
some answers are given to the user (e.g., metabolic syndrome, the unique 
contribution of each risk factor), we are not sure why participants failed to utilize 
these resources. Either way, we believe that more training and familiarity would go 
a long way to improve performance when using the ecological display. 
 The second factor is that of the stimulus presentation method for the 
ecological display. We believe that one of the compelling aspects of the ecological 
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display is the ability to make changes in the display and see the dynamic changes 
made in real time. We suspect that the static paper displays did not allow the 
residents to benefit from these abilities.  
 The third factor to consider is whether we actually captured the essence of 
the detection, evaluation, and treatment task for hypertension and hyperlipidemia. 
Although our medically trained advisors reviewed our tasks, we still may not have 
been asking the questions that are most meaningful or would allow the ecological 
display to demonstrate its strengths.  
We are aware of a number of limitations with our research and its design. 
One question we cannot answer is whether either the number line or ecological 
displays are better than the alphanumeric display. We did not incorporate the 
alphanumeric display because we estimated that we would not be able to run 
enough trials with participants to collect a meaningful sample size due to potential 
time limits with physicians. We chose the number line for two reasons. First, many 
of our medical advisors believed that anything would be better than the 
alphanumeric format. Second, using the number line format against the ecological 
display would allow us to compare a configural display (the ecological display) to a 
separable display.  
Second, all of our participants were evaluated simultaneously and had the 
cases presented to them in the same order. We could not control for environmental 
distractions or for any order effects. We initially planned to randomize the case 
presentation order and meet with participants individually, but when the last 
minute opportunity arose to conduct the research with 23 participants at one time, 
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we made as many adjustments to the study as we could, but trade-offs had to be 
made. In the end we could not control for order effects or environmental 
distractions, but we benefited from having a larger sample size and more cases to 
evaluate than we might otherwise would have.   
Third, while we believe that insufficient training played a part in some of the 
responses, there was another issue with the treatment responses. This was that we 
were not able to differentiate between those who knew the guidelines and disagreed 
with the treatment and those who did not agree with the guideline because they did 
not know the guideline recommendation and chose differently. 
 Given the exploratory nature of this work, we tried to maximize the variation 
in the cases we presented to our participants, while preserving some aspects, in 
order to try to come to a sense of which questions might be important. To this end, 
we created patient pairs. However, due to the number of risk factors and their 
interactions, small differences (even just a few points) in the risk factors meant that 
we could not compare cases to each other or control for the various risk factor 
levels.  
 However, in spite of the weaknesses, we believe that this study has provided 
a useful starting place for future research and has provided us with some more 
refined research questions. As we mentioned, we were concerned about the inability 
for participants to fully engage with the ecological display in this study, so we chose 




5. DYNAMIC DISPLAY EVALUATION & USABILITY 
INTERVIEWS
5.1. Overview 
 The second part of this dissertation research consists of quantitative and 
qualitative components. The quantitative component builds on the evaluation of the 
ecological and number line displays during the previous study by having 
participants use an interactive version of the ecological display in order to provide 
users with a better sense of the domain dynamics. The qualitative component 
included observations and interviews and focused exclusively on the ecological 
display in order to provide us with a better understanding of potential usability and 
usefulness issues.  
5.2. General Method 
5.2.1. Participants 
 Five participants were involved in this study. Two were faculty physicians 
with nearly 30 years of experience; one was associated with a department of family 
medicine and the other was associated with a department of internal medicine. Two 
participants were completing their residency in a family medicine/psychiatry 
program; one was a first year resident, the other was a fourth year resident. The 
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final participant was not a physician, but a registered nurse who had more than 20 
years of patient education experience. Ages were not collected. Three participants 
were female and two were male. 
 The nurse completed only one patient case during the quantitative 
evaluation and therefore had her data excluded for that portion. However, she had 
many valuable insights during the qualitative portion and her data was included 
there. 
 Participants were personal contacts of the author or of the medically trained 
advisors associated with this research and were associated with two Ohio medical 
schools.  Although sampling was primarily a matter of convenience, attempts were 
made to obtain participants across a range of experience. Seven participants were 
originally recruited, but two were not able to participate due to scheduling conflicts.  
 The study and interviews were conducted at each participant’s workplace 
within a quiet office. Although the doors were closed, we could not eliminate all 
distractions due to the nature of our participants’ work. We informed all 
participants that they would have their name entered into a drawing for an iPad® in 
exchange for their participation.   
 The Wright State University Institutional Review Board approved this 
research. 
5.3. Part 1: Interactive Ecological Display Evaluation  
 There were two purposes of the quantitative evaluation. First, we believed 
that a major benefit of the ecological display was that it would allow the physician to 
engage in “what-if” experiments with patient data, allowing them to visualize how 
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changes influenced the recommended treatment. We believed that this ability would 
increase the frequency of making treatment decisions that agreed with the 
respective guidelines when using the ecological display. To evaluate this hypothesis, 
we had our participants complete a simplified version of the DET task used in the 
previous study. In the simplified task, we also provided 12 trials (also from six 
patient pairs) to the participants, but only asked participants to prescribe a 
treatment instead of also deciding which factors to follow-up on or rank risk factor 
severity.   
Second, we believed that graphically representing the ATP-III and JNC-7 
guidelines in the ecological display format would increase the physician’s 
confidence in how well their prescribed treatment agreed with the respective 
guidelines. This does not imply that the recommended guidelines are the correct 
answers, but simply whether the participant felt that their decision matched that of 
the respective guidelines.  
5.3.1. Method 
5.3.1.1. Materials and Procedure 
We used twelve electronic images to present the patient data in the present 
evaluation. As with the previous study, patients were classified into six Patient Pairs, 
with half of the trials being in the ecological condition and the other half in the 
number line condition. Unfortunately, there was an error with the naming 
convention used that led to the accidental use of dissimilar patients in one the pairs, 
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so we had to discard the data from one pair and left us with five Pairs.  These five 
scenarios are outlined in Table 10. 
We presented the stimuli to the participants with a laptop computer with a 
16” monitor (with a screen resolution of 1600×900 pixels) that used the Windows 7 
operating system. We used Techsmith’s Morae (version 3.2) to capture video of the 
computer screen as the participant interacts with the displays.  Morae also allowed 
us to record both the participants’ faces and the audio dialog using the computer’s 
integrated video camera and microphone. A portable computer mouse was also 
provided for greater convenience.  
The displays used in the number line cases measured 535×840 pixels and 
were not interactive. They were presented to the physician using Windows Photo 
Viewer®. For the ecological display condition, participants used the ecological 
display software program that we developed. This software was simply an 
interactive version of the ecological format used in the previous study that allowed 
users to manipulated the various risk factor levels in order to effect change in the 
display.  The ecological displays measured 1420×840 pixels in dimension.  
Stimulus presentation order was not randomized because we were worried that full 
randomization may have left us without any completed pairs to use for comparison 
because of the low number of participants and did not know how many trials each 
participant could complete in their allotted time.  
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Table 10  Paired Stimulus Scenarios for the Interactive Evaluation 
Pair # Cholesterol Tx SBP Tx Context/Rationale 
1 DT DT 
Patients could quit smoking to 
move from DT for cholesterol 
to NT 
 
2 NT TLC 
Patients had enough risk 
factors to have metabolic 
syndrome  
 
3 TLC NT 
Although patients have low 
LDL cholesterol that would not 
normally require treatment, 
their diabetes places them into 
the high risk area and requires 
TLC 
 
4 TLC NT 
Patients have many treatment 
modifying risk factors that 
suggest TLC for cholesterol 
instead of NT if fewer factors 
were present 
 
5 TLC TLC 
Patients with high 10-year risk 
due primarily to age 
 
  
In the task instructions, we asked participants to prescribe and verbalize 
their treatment decision for both cholesterol and blood pressure for each trial. As 
with the previous study, the treatment options were no treatment (NT), therapeutic 
lifestyle changes (TLC), or drug therapy (DT).  We avoided interrupting the 




Guideline Agreement.  
We had two measures for guideline agreement, one for ATP-III and one for 
JNC-7. Given the small sample size, we defined guideline agreement as the number 
of participant responses that matched the guideline recommended treatments for 
each condition (hypertension and hyperlipidemia) for each patient trial.  
Guideline Confidence. 
 We measured guideline confidence for both ATP-III and JNC-7 guidelines. To 
measure confidence, we asked participants to rate how confident they were that 
their decision matched that of the respective guideline on a 7-point scale (1= Not at 
all confident and 7 = Extremely confident). If a participant failed to mention the 
rating before moving on to the next trial, we briefly interrupted the new trial and 
reminded them to provide ratings for the previous trial.   
5.3.1.3. Procedure 
Once we had made contact with our medically trained participants, we 
arranged to meet with them in their respective offices. Upon arrival, we provided a 
brief overview of the study and provided an informed consent form from which we 
obtained their written consent. While participants reviewed and signed the consent 
form, we set up the laptop computer on a desk in an area that the participant 
designated.  
After obtaining participants’ consent, we opened up a sample number line 
trial for the participant to view while we read from a script detailing the task 
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instructions (see Appendix C) and describing how to interact with Windows Photo 
Viewer® to advance through the number line trials. We also informed participants 
that they would be able to review their answers at the end of the block. 
In that our appointments with the physicians were limited to 60 minutes, we 
wanted to ensure that we had time to collect data from the DET task for both 
graphical conditions as well as an interview. To ensure that there was time left for 
the interview, we had to limit the time spent on the DET task. We limited the time 
allotment for each graphical condition to about 10 minutes. With the addition of the 
instructions, consent review, and set-up, the total duration of the DET task was 
about 30 minutes. However, these times are approximate because the purpose of 
the time limit was to allow us some time for the interview, not timing how long it 
took to complete a trial. If a participant was in the middle of a trial after 10 minutes 
had elapsed, they were allowed to finish the current trial before we moved on. This 
process also meant that some participants did not finish every trial. 
Once the participant had finished the last trial, we opened a sample 
ecological display and read from a script that described the task instructions and 
provided an introduction to the ecological display. As with the number line block, 
we informed participants that they would be able to review their answers at the 
conclusion of the block and that they would be able to interact with the display as 
we read through the task instructions. We also instructed participants on how to 
interact with the Windows 7 operating system to view and close each instance of the 




5.3.2. Simplified DET Task Results 
Given the few data points for the DET task, we have opted to provide the data 
here in lieu of formal analyses (see Table 11).   
For Patient Pair 1, all four participants made decisions in agreement with the 
ATP-III guidelines and 3 of 4 participants agreed with the JNC-7 guidelines when 
using the ecological display while not making any decisions in agreement with the 
number line display. Display type seemed to have little effect for the other Patient 
Pairs as demonstrated by the similarity in scores between the display types (e.g., 0 
vs. 1 for ATP-III or 4 vs. 3 for JNC-7 in Patient Pair 2).  
Guideline confidence was high across all Patient Pairs. Almost all participants 
reported confidence scores of 6 or 7. Only participant S3 (30+ years of experience) 
chose confidence scores other 6 or 7.  In Table 11, we have highlighted participant all 
of S3’s Confidence scores below 6 in gray. Note that with the exception of the 
ecological display for Patient Pair 1, all responses less than 6 are for the number line 
condition. We wonder if this participant was better “calibrated” than the others, 
given that there seemed to be some measure of overconfidence for all participants 




Table 11 Guideline Agreement and Confidence Tables 
   Guideline Agreement  Guideline Confidence 
   ATP-III (3) JNC-7 (3)  ATP-III  JNC-7  
Pair Participant  NL ECO NL ECO  NL ECO NL ECO 
1 
S1  2 3 2 3  7 7 7 7 
S2  2 3 2 3  6 7 7 7 
S3  1 3 1 2  5 7 7 5 
S4  2 3 1 3  6 6 6 6 
  Agreement 0 4 0 3 
       
       
   ATP-III (1) JNC-7 (2)  ATP-III  JNC-7  
   NL ECO NL ECO  NL ECO NL ECO 
2 
S1  2 2 2 2  7 7 7 7 
S2  2 1 2 1  6 7 6 7 
S3  3 2 2 2  3 7 5 7 
S4  2 2 2 2  6 6 6 6 
  Agreement 0 1 4 3 
       
       
   ATP-III (2) JNC-7 (2)  ATP-III  JNC-7 
   NL ECO NL ECO  NL ECO NL ECO 
3 
S1  2 2 2 2  7 7 7 7 
S2  3 2 3 2  6 6 7 7 
S3  2 2 2 2  4 6 7 7 
S4  -- -- -- --  -- -- -- -- 
  Agreement 2 3 2 3 
       
       
   ATP-III (2) JNC-7 (1)  ATP-III JNC-7 
   NL ECO NL ECO  NL ECO NL ECO 
4 
S1  3 3 3 2  7 7 7 7 
S2  3 2 3 3  6 6 7 7 
S3  2 2 2 2  2 6 7 7 
S4  -- -- -- --  -- -- -- -- 
  Agreement 1 2 0 0 
       
       
   ATP-III (2) JNC-7 (2)  ATP-III JNC-7 
   NL ECO NL ECO  NL ECO NL ECO 
5 
S1  3 3 3 3  7 7 7 7 
S2  3 3 3 3  6 6 7 7 
S3  -- -- -- --  -- -- -- -- 
S4  -- -- -- --  -- -- -- -- 
  Agreement 0 0 0 0 
       
        
 
 Total Guideline 
Agreement  
3 9 6 9 
       
Note. Guideline treatment recommendations are in parentheses in the LDL Tx and BP Tx column 
headings; 1=No Treatment, 2=Therapeutic Lifestyle Change, 3=Drug Therapy.  
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5.4. Part 2: Ecological Display Usage 
The second objective of this study was to investigate issues of use and 
usability of the ecological display. To meet this objective, we observed participants’ 
usage and interactions with the ecological display as well as conducted semi-
structured interviews about their experiences with it.  
5.4.1. Method 
5.4.1.1. Observations 
During the quantitative portion of this study, we recorded participant 
interactions with the screen capturing software. Two researchers reviewed the 
resultant audio/video data and coded the participants’ usage behavior. Usage was 
measured as the number of times that participants either referred to directly or 
used the mouse to interact with the various graphical elements of the ecological 
display (i.e., the number line, risk function curve, contribution bar chart, blood 
pressure bar chart, treatment option matrix, and pentagons) while they completed 
the DET task for each of the ecological display trials.  
 In that the number line element contained so many data elements and played 
such a significant role in the DET process, we divided it into four smaller areas for 
coding purposes. These areas were the top section (which includes the yes/no 
switches for dichotomous variables along with the age number line), the cholesterol 
area, the blood pressure area, and the risk value. Any time a participant navigated 
(verbally or with the mouse) among these areas, we assigned a point to the number 
line element tally. According to this coding scheme, participants used the number 
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line at least three times every case (once for the dichotomous variables and age, 
once for cholesterol, and once for blood pressure).  
Discrepancies between the researchers were reviewed until consensus was 
reached. However, there were a few cases in nearly every trial where coding was 
impossible for verbal remarks. For instance, when addressing 10-year risk, many 
participants made a comment along the lines of, “the patient’s risk is higher than I 
would like” without verbally reporting or using the mouse to indicate which source 
of data was used. Without accurate coding for these few cases, we are likely 
underestimating actual usage.  
5.4.1.2. Interviews 
Upon conclusion of the simplified DET task, we presented all five participants 
with one final ecological display and began the short semi-structured interview. We 
used three standard probes in these interviews to supplement and enhance our 
understanding of usability issues related to the ecological display. These were: (1) 
What do you think is confusing about the ecological display? Is it something that 
training could resolve? (2) What features would you like to see implemented or 
removed and why? and (3) Would you use the ecological display in your practice? 
Why or why not?  
  All interviews lasted between 15 and 30 minutes. Once the interview section 
had been concluded, we thanked the participants for their time and debriefed them 




5.4.2.1. Graphic Element Usage 
Overall, the number line component had the most use (GM = 6.74, SD =3.44; 
see Figure 21), followed by the treatment option matrix (GM = 1.53, SD = 1.64), JNC-
7 bar chart (GM = 1, SD = 1.28), function curve (GM = 0.79, SD = 0.97), pentagons 
(GM = 0.42, SD = 0.94), and contribution graph (GM = 0.21, SD = 0.7). Taken 
together, the number line component was used, on average, roughly 1.6 times more 
often than everything else combined.  
 Although the number line component had the most usage, the JNC-7 bar 
chart and ATP-III treatment option matrix were also used at least once on average 
for each trial. The pentagons were little used, but the contribution graph was used 
even less frequently. In some respects, this surprised us in that we believed that the 




Figure 21 Ecological Display Usage Statistics by Case and by Graphical Element 
5.4.2.2. Observations and Interview Responses 
In response to the question about confusion with the ecological display, one 
faculty physician stated that, “you need to be walked through [the ecological 
display], but once you are walked through it, it’s pretty clear. […] Like anything else 
computerized, you have to get used to looking at it. It’s really pretty clear.” All five 
participants indicated that the ecological display was confusing at first glance but 
that some instruction and experience with it made it simple to use.  
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 The sense of confusion from the ecological display came from a number of 
sources. Perhaps unsurprisingly, all the graphical elements received a comment or 
observation at some point. In that every element was implicated as a potential 
source of confusion, we will present the results of the responses and observations 
starting with the number line area, then the function curve, blood pressure bar 
chart, treatment option matrix, and ending with the pentagons.  
Number Line Area. 
None of the participants mentioned the data-input number lines specifically 
during the interview, but some did ask for clarification during the simplified DET 
task. Two physicians asked once for clarification about how to read the graphical 
switches for dichotomous variables (e.g., smoking) once; the nurse asked three 
times. 
 There were some mixed responses to the coloration of the number line bars 
and the colors used to indicate the risk factors themselves. Two physicians 
mentioned that they felt the colors should be even brighter. Three physicians 
mentioned that they liked the color schemes and felt that it helped distinguish the 
risk factors from each other. However, the nurse kept referring to the colors as 
“grey” and reported difficulty distinguishing between smoking, age, and diabetes 
statuses.  
Only one of the physicians mentioned the potential problem associated with 
red-green color blindness. Two participants mentioned that they felt the red-yellow-
green coloration was helpful. 
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 There were complaints about the abbreviated labels such as “FamHx,” 
“>110mg, and “>100mg.” The label for fasting blood glucose (i.e., >110mg) was 
brought up by all participants at least once, either to verify what it was or if the 
metric was supposed to be noted as “>110 mg/dL.”  
Function Curve. 
The function curve did not elicit any specific complaints, but there were two 
comments about it being intimidating without training. There was a sense of 
usefulness of this component, particularly when seeing the difference that toggling 
smoking status has. One physician felt that the ability to see the change in risk that 
smoking cessation could have was important for the patient to see. He stated, “[…] I 
think the real beauty of something like this is that I’m cutting [the patient’s] risk 
from 9.6 to 5. That’s hugely dramatic with just the click of a button. […] I think that 
might convince a patient or two.”  
Contribution Bar Graph. 
 One physician noted that it was difficult to notice or distinguish between risk 
factors when the contribution of one risk factor is only a few pixels wide and is 
placed next to another risk factor that shares a color or luminosity with the first. For 
instance, a contribution of total cholesterol (dark blue) only 2 pixels might be lost if 
placed next to contribution of systolic blood pressure (dark purple) that is 30 pixels 
in width.  
 None of the participants had complaints about how the contribution bars 
align with each other (i.e., the base of the top bar begins at the top of the bottom bar 
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instead of both originating in opposite directions from the y-axis), which is one issue 
we expected to hear about. However, this may have been because we explained the 
relationship in the instructions.  
Blood Pressure Bar. 
 The nurse asked for clarification on the colors used in the bar. This makes 
sense in that this bar uses not only the red-yellow-green color scheme to indicate 
severity and treatment options, but it adds orange into the color scheme as well. 
There are two DT options for blood pressure in the JNC-7 guidelines and we used 
red for the most severe case and orange for the less severe case. Given that orange is 
a mixture of both red and yellow; we can see how the color orange may send a 
mixed message.  
 One of the residents did not immediately understand that the bars were 
scaled according to the severity and treatment recommendation (e.g., the green 
portion of graph field representing values for both SBP and DBP that were values 
that did not require treatment) rather than being scaled numerically. When we 
explained the logic to him, he indicated a preference for the severity/treatment 
scaling over the strictly numeric scaling after all.  
Treatment Option Matrix. 
 The only issue mentioned or observed with the TOM was when one physician 
suggested that the colored regions have labels directly placed on them or to have a 




  One resident liked the pentagons, but reported that, “having the metabolic 
syndrome and the risk factors [there] is kind of busy. Maybe you could click on [that 
area] separately…click on it and have a box come up […] cuz it’s a little busy.”  One 
faculty physician stated that she “would remove the two pentagons because they 
have not helped [her] at all.” There were no other quotations about the pentagons 
directly, but we did observe one resident expressing surprise at noticing that one of 
the trials met the criteria for metabolic syndrome and had not realized that fact 
before he had looked at the pentagons. 
Overall. 
All participants indicated that they would like to use the display in their 
practices, however, not all wanted the ecological display to be the format in which 
test results were initially presented. Two of the physicians indicated that they 
wanted the test results returned to them from the laboratory in ecological format 
initially, one faculty physician wanted results presented in the traditional 
alphanumeric format, and one resident wanted results presented in the number line 
format. In spite of the mixed preferences, all participants felt that the ecological 
display would be helpful to at least have easily accessible for “the complex patients.” 
A few physicians mentioned that although they would like to use (or have available) 
the ecological display, it would be necessary for the patients’ data to be 
automatically populated (i.e., from an electronic medical record) into the display for 
them to use it for decision-making purposes.  Its use for decision-making was 
contingent upon whether they had to enter the data manually or not.  
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One commonly reported reason for using the ecological display was the 
ability to see the Framingham model, ATP-III, and JNC-7 guidelines presented in a 
visual format. Everyone made at least one positive comment on how the ecological 
display reduced the need to “try and remember the guidelines.” As one resident 
reported, the ecological display would “speed things up” for him because he would 
not “have to think of the guidelines in his head.” Another resident agreed on this 
point, and added that this format would “force people to use evidence-based 
practice.”  
All participants also mentioned that the ecological display would be a helpful 
tool for patient education, particularly for the ability to make adjustments with the 
data and see real-time changes. As one enthusiastic faculty physician put it,  
“I like the ability to show the patient the impact of the changes that we’re 
trying to make. Lovely for motivating patients. […] This is powerful for a 
patient—they can actually see what they are doing. You’re giving the patient 
something. […]This makes it easy and easy is really important. […] It’s nice to 
have something simple and graphic in front of you to say [to the patient], 
‘You’re doing the right thing,’ or ‘this is what we’re recommending’. Right 
now EMRs are designed to deal with billing as opposed to helping us take 




5.5.1. DET Task 
Taken as a whole, we believe the results from the quantitative portion hint at 
a possible effect for the ecological display leading to greater agreement with the 
published guidelines. The link between display and guideline confidence seems a 
little weaker than that of agreement. Guideline confidence was particularly puzzling 
between JNC-7 confidence and JNC-7 guideline agreement for Pairs 4 and 5 (both 
display conditions) because in spite of the maximum confidence ratings, none of the 
participants actually chose a treatment in agreement with the JNC-7 guidelines. 
When using the ecological display, participants followed the ATP-III 
guidelines in four of the five patient pairs. For the JNC-7 guidelines, participants 
followed the guidelines with the ecological display in three of the five patient pairs. 
Obviously the sample size limits the conclusions that we could draw from these 
results, but the results at least offer a basis for warranting additional research.  As a 
pilot study, the ecological display seems promising. 
We should also emphasize that even if additional future research were to 
support greater guideline agreement, it would not necessarily indicate superiority 
for the ecological display for the reason that some physicians felt that their 
treatment was best for the patient regardless of what the guidelines suggested. 
Following the guidelines does not necessarily equate to doing what is best for the 
patient. Determining whether the ecological display influences physicians to follow 
guidelines at the expense of what is best for the patient makes for an important 
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future research topic, but is certainly outside of what we were able to accomplish at 
this time.  
 In terms of guideline confidence, participants expressed greater confidence 
that their treatment decisions matched the ATP-III guidelines in four of five patient 
pairs, yet only once for the JNC-7 guidelines. However, it should be noted that for the 
JNC-7 guidelines, participants’ responses for three of the five patient pairs were tied. 
This is not so surprising given the degree of difference in steps required. The JNC-7 
guidelines were much simpler in that they did not contain any information that was 
not already contained in the threshold levels used to delineate the severity levels, 
whereas the ATP-III guidelines required a 9-step process.  
 The same limitations apply to the results of the guideline confidence as for 
the guideline agreement. Future research is certainly needed, but we are not sure 
that asking about the confidence that their answer matches the guideline is the best 
question after all. This again returns back to the issue of whether the guidelines are 
the best thing for patients. A physician may feel very confident that their response 
does not match that of the guideline but feel very confident that they are making the 
best decision over all.  
5.5.2. Interview and Observations 
 Aggregated together, all graphical display elements were used at some point. 
We interpret this to mean that although there are some mixed feelings about some 
of the graphical elements, each element could be a useful source of information for 
users. However, it should be noted that these results do not necessarily negate the 
less frequently used elements because we have reason to believe that they are a 
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result of the task, not of their inherent usefulness. We had participants complete a 
simplified DET task, which means that we asked participants to make a decision 
about treatment, not to reason about their decisions.  We assumed that the 
reasoning process would have been inherent in the decision making process, but 
this may not be the case.  One medically trained advisor admitted that she thought 
of the reasoning process as separate from the treatment decision-making process.  
If this were true, then future research would likely find that the less frequently used 
graphical elements (e.g., the function curve, contribution bar graph, and pentagons) 
would become more frequently used. In terms of  
5.5.3. Weaknesses 
We recognize that we had to make some trade-offs that left us with some 
drawbacks with this present study. First, our sample size was not large enough to 
provide meaningful statistical information.  Although we cannot make any 
declarations of statistical significance, we believe that there is some evidence to 
warrant further research. Second, in order to get participants to finish enough trials 
(due to the time constraint) across both conditions, we had to standardize the 
presentation order. This meant that we gave up the benefit of randomization, but on 





6.1. Study Overview 
The purpose of this dissertation research was to evaluate the usefulness and 
usability of an ecological display developed to aid providers in the detection, 
evaluation, and treatment of cardiovascular disease. In order to accomplish this, we 
used both quantitative and qualitative methods with physicians of varying degrees 
of experience. Our primary purpose of carrying out this research was exploratory in 
nature rather than designed to test any specific hypotheses. In this, we believe that 
we have made some observations from the data that warrant further research.  
 First, when the cases in a Patient Pair met the criteria for metabolic 
syndrome, participants were significantly more likely to only indicate the need for 
follow-up when using the ecological display than the number line display.  These 
findings are not too surprising given the fact that the ecological display provides the 
answer using the pentagon display along with some text.  
 Second, there was a trend for the ecological display to lead to greater 
guideline agreement than with the number line display. However, this pattern was 
only a trend, which was curious in light of the fact that the answer was figuratively 
spelled out for the user. We suspect that a lack of familiarity and training partially 
contributed to these findings, but we are unsure if certain risk factors or even a 
general disagreement with the guidelines contributed as well. Perhaps combining 
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multiple CVD risk models, such as the Framingham and Reynolds risk models along 
with the ATP-III guidelines would lead to suggested treatments that physicians 
would be more likely to agree with.  
Third, we originally planned on comparing the number line format to the 
ecological format because our initial inclination was that any display format would 
have been better than the traditional alphanumeric format. We believe that it would 
be worthwhile to go back and revisit our initial assumption, especially in the light of 
having obtained fewer significant differences in every measure than we had 
expected.   
Fourth, the ranking results were mixed. We are not sure why this is the case 
in spite of the fact that the answers were also figuratively spelled out for the 
participants.  There was a sense from our advisors and participants that 
determining the most important risk factors for the patient was important, so we 
would like to refine our method and try again.  For instance, we think that creating 
pairs that are matched according to the severity of risk factors instead of the 
treatment option would be a good start.  
Although we had some mixed results overall, we believe that we have made 
an important first step in bringing forth an ecological display that physicians find 
useful and usable. Although our display certainly requires further work before 
“releasing it into the wild,” our partners and participants have received it with 
enthusiasm and support, indicating to us that we are on the right track.    
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6.2. Ecological Interface Design  
For us, the major lesson from McGregor & Slovic (1986) is that graphical 
displays are only as good as the semantic mapping they have with their respective 
ecologies. Not only must a user be able to make sense of the display, but the display 
must also be a good representation of the domain in order to equate meaning with 
interpretation. Representing the domain well requires a conscientious effort to 
research the domain to discover the laws and constraints of the domain.  
What we have tried to accomplish with our display is similar to that which 
has been done in domains as varied as aviation (Amelink, Mulder, van Passen, & 
Flach, 2005), power production (Schaefer, Little, Copper, & Easter, 1987; Woods, 
Wise, & Hanes, 1981; Bennett, Payne, Calcaterra, & Nittoli, 2000), process control 
(Bennett, Nagy, & Flach, 1997), military command & control (Bennett, Posey, & 
Shattuck, 2008), and even fictional literature search (Petjersen, 1992). However, 
one major difference between our work and that of the aforementioned work is that 
we have chosen to use a correlational model as a functional constraint (i.e., the 
Framingham risk model) rather than conceptual models (Pejtersen, 1992) or 
physical systems described by (partial-) differential equations (Amelink, Mulder, 
van Passen, & Flach, 2005, Bennett, Nagy, & Flach, 1997).  
While there is nothing in the ecological interface design principles that 
precludes the use of correlational models, we are unaware of their use in existing 
work. We hope that our use of a correlational model will serve as an additional tool 
in the ecological interface designer’s toolbox.  Furthermore, we suspect the use of 
correlational models may have pedagogical value because many in the human 
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factors (and similar disciplines) are more familiar with correlational models than 
they are of physical systems based on differential equations.  
In our search for domain constraints, we had to rely upon the medical 
science to tell us what was important. We assume that medical science has 
improved since medieval times and that our current models of risk are far more 
accurate and efficacious than what could be divined from astrology and planetary 
motion, but validity of current medical models in the hands of those researchers.  
Our job has not been to refine the medical science or create new models of risk, but 
to use existing knowledge to develop a display capable of presenting the 
complexities of the domain models to healthcare providers. We believe that the 
positive response to our display from our participants indicates that we may be on 
the right track, but we hope that we have not simply created a display that is 
marginally better than the manuals used by medieval doctors. The success of any 
ecological display used in healthcare will always depend on the quality of the 
models it represents. 
6.3. Future Design  
Although we believe that we are on the right track with our display, there are 
still a number of design issues that we think should be addressed. The first, and 
possibly the most obvious, is the need to address the issue of color in light of 
potential problems for those with color blindness. We agree that our display should 
be more usable to those who are color blind, particularly red-green blindness, 
because those colors are prominently used throughout. However, we would hate to 
lose the red-yellow-green/bad-warning-good cultural convention by eliminating 
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them. However, we think that redundantly coding them with a texture or pattern 
may be a potential solution.  
Second, there were a number of complaints about the pentagons. At the same 
time, a number of participants requested additional data, such as body mass index, 
height, and weight. Given the suggestions and complains, we wonder if we would we 
be better off removing the pentagon and replacing it with other data or another 
graphical element. Regardless, additional research is needed in this area. 
Third, we have two bars for systolic and diastolic blood pressure. There are 
bars in the number line portion of the display as well as beneath the contribution 
bar graph. From the systolic blood pressure contribution of the contribution bars 
are a set of splayed lines that connect to the JNC-7 bars. On one hand, these lines 
make an explicit connection between the risk model and the JNC-7 guidelines, but 
we believe they do the job rather inelegantly. We wonder if the splayed lines are 
necessary. Another aspect to consider is whether we need two sets of bars for blood 
pressure. There is nothing contained in one set that is not in the other. The only 
difference is that the bars in the JNC-7 area are scaled according to severity rather 
than numerically. We could potentially eliminate one set of bars and keep them on 
the same severity scale, which would free up some additional space for additional 
information. 
Fourth, there are also a number of factors that are dichotomously measured 
in our display (e.g., waist circumference, fasting glucose, etc.) that our participants 
have suggested to be displayed continuously on number lines. We agree that this 
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would be a welcome addition to the display, even though the precise measurements 
are not used in the Framingham risk model or criteria for metabolic syndrome.  
Fifth, we have not addressed changes over time and historical data.  While 
this is a limitation of any number line or bar chart, not just our display, it still 
remains an issue on how to (or if we should) represent multiple readings for the 
various risk factors and outputs (e.g., 10-year risk levels and treatment options).   
However, all of this raises the larger issue as to the scope of this display. 
Although we agree with our participants and medical advisors about the 
inclusion of additional data, we recognize the fact that we run the risk of trying to 
display too much at once if we add any more to it. Data overload was one of the 
problems we tried to address by creating this display in the first place. Creeping 
featurism is a problem we want to avoid.  
The future scope of this display will be determined by the development track it 
lands in. On one hand, if this display were to be a stand-alone product (e.g., as an 
iPad® app), then we would need to consider the inclusion of additional information 
more closely because we do not want to leave our practitioners without the data 
that they need. On the other hand, if this display were included in an EMR system 
that was connected to a database of all patient data, then the need to include the 




6.4. Concluding Remarks 
As we mentioned earlier, we were not interested in creating a display from 
which experts and specialists could extract new models of cardiovascular disease 
and risk, but rather providing users with a quick entry into the decision making 
process with the medical guidelines as the starting point rather than as the 
endpoint. 
We would also like to re-emphasize that while we attempted to make our display 
easy to use, some of our participants struggled with it (although some may have just 
disagreed with the guidelines). This should not be taken as evidence that our display 
is “user-hostile,” but rather that we are asking medically trained physicians to 
complete a difficult task in the face of ambiguity in that the “correct” treatment for 
the patient does not necessarily have to correspond with the guidelines and some 
participants wished for additional data.  However, this goes back to one of the 
misconceptions that people often have about ecological interface design.  The point 
is not to create a simple interface. The point is to provide an interface that allows 
people to see, reason about, and interact with the ecology rather than the interface 
per se.  Complex domains require sophisticated displays in order to capture the 
meaningful aspects of the domain.  If a display is too simple, it runs the risk of 
trivializing the domain and becomes useless (or harmful) when the display cannot 
adequately represent the complexity of the domain. The law of requisite variety 
(Ashby, 1958) must always be respected for a display to remain successful. This 
may translate into the creation of a display that is sophisticated enough that may, 
depending upon the complexity of the domain, require training.  
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We hope that our display will have the opportunity to become refined after this 
initial development process and become something that people will use, regardless 
of a standalone product or as an integrated function of an EMR system. Whether or 
not this display is implemented as a professional tool, we hope that it at least serves 
as inspiration to designers to move beyond the dyadic world of colors, shading, and 





Data Collection Packet Sample 
1.) How concerned are you about this patient’s health based on these results?        
  
 _______ Not concerned at all, seems to be in good health 
 _______ A little concerned, there is some risk present 
 _______ Quite concerned, there are several worrisome findings 
 _______ Very concerned, there are significant worrisome findings 
 
2.) Place a check mark next to the cardiovascular risk factors that you would address with the patient:  
 
 Total Cholesterol  Smoking 
 LDL Cholesterol  Obesity 
 HDL Cholesterol  Blood Sugar 
 Triglycerides  Metabolic Syndrome 
 Systolic BP   
 Diastolic BP   
 Diabetes   
    
 
3.) How would you treat the following risk factors in this patient? (Check corresponding box) 
 
 Treatment Option 
Risk Factors No Treatment Lifestyle Change Drug Therapy 
Total Cholesterol    
LDL    
HDL    
Triglycerides    
Systolic BP    
Diastolic BP    
Smoking    
Diabetes    
Obesity    











4.) Rank the following CVD risk factors in order of severity for this patient by placing a number next to each risk 
factor (1 = increases CVD risk the most to 6 = increases CVD risk the least; use each rank number only once): 
 
Total Cholesterol __________ 
HDL Cholesterol __________ 
Systolic BP __________ 
Diabetes __________ 
Age __________ 
Smoking Status __________ 
 
 





Demographic Information  






Year in Residency Training:____________________ 
 
What is your race? 
 ___ White  
 ___ African-American 
 ___ American Indian or Alaska Native 
 ___ Asian  
___ Pacific Islander 
____ Some other race or mixed (please specify):________________________________________  
 
Ethnicity: 




Script for Static Display Evaluation 
Thank you for coming today. We appreciate Drs. [X] and [Y] for letting us come and 
meet with you. The purpose of our visit is two fold; first, we want to share some of our work 
with you in the field of graphical display design, particularly in ways of displaying patient 
information. Secondly, we are here to solicit feedback from you in terms of our work and 
how this display influences decision-making. To this end, we have provided you with a test 
and ask for your participation in our research. 
 In front of you, you should find a packet of paper. The top is a letter of informed 
consent for this research.  As many of you may know, participation in any research is 
voluntary.  If you choose not to participate, you may find this to be an interesting exercise 
anyway and we encourage you to follow along even if you decide not to return your 
responses to us. We will not share your personal information or results with any faculty.  If 
you are interested, we will be happy to provide you with the group results when we finish 
analyzing the data. Regardless of whether or not you choose to participate in the 
experiment, the last page of the packet has a section where you can enter into a drawing for 
an iPad. Please take a few moments to decide whether you want to participate and review 
the informed consent document. Once we have your consent, we will proceed with the task 
instructions.  
 
You are to imagine that you have added a new male patient to your practice yesterday. 
During your examination, you ordered a lipid panel for this patient. You were also able to 
have some of the patient’s medical information transferred over from his previous 
physician. Today, the results have returned from the lab and it is now time to review them 
and make a decision about how to proceed.  
 
We will provide you with this patient data in a moment once we have completed explaining 
the task instructions. This patient information will be provided to you as a packet of papers. 
Each page represents one patient. There are 12 pages representing 12 different male 
patients. Your task will be to view this data and make decisions about treatment. Once you 
have made a decision, please move on to the next patient and do not go back to review data 
or change your answers from previous patients.  
 
You will have access to the following medical data: 
 
 If he has existing heart disease (i.e., clinical CHD, symptomatic carotid artery 
disease, PAD, abdominal aortic aneurysm) 
 If there is a family history of CHD (i.e., 1st degree relative with CHD; male < 
55 or female < 65) 
 If the waist circumference is greater than 40 inches or 102 cm 
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 If fasting blood glucose is ≥ 110 mg/dL  
 If he was previously diagnosed with diabetes mellitus 
 If the patient smokes 
 Age  
 Cholesterol levels 
 Total Cholesterol, HDL, LDL, and triglycerides 
 If he is currently on antihypertensive medication (Y/N) 
 Blood pressure 
 Systolic and diastolic 
 10-year risk for cardiovascular disease (Framingham Model) 
 
After reviewing this data, you will need to answer a number of questions found in the 
packets that we have provided underneath the informed consent page. There is an answer 
sheet for each patient. When you get to question 4, you are to rank order the severity of 
each risk factor for this particular patient by assigning it a number from 1 to 6, where 1 
means it increases that patients risk the most and 6 means it increases it the least. Use each 
number only once. None of the risk factors should share a number. If you feel that you need 
to explain any of your answers or believe that you would do something other than the 
options we have provided, please feel free to use the additional notes section at the bottom 
and feel free to write on the back of the page if need be. Please answer these questions to 
the best of your ability.  
 
You will be shown the patient data in two different graphical formats. We will now briefly 
introduce these formats to you. As you can see, there are two numbers here. Number 1 
represents the data as presented in a number line format. Some of the risk factors are 
dichotomous. These are: existing heart disease, family history (fam Hx), waist 
circumference above 40 inches, blood sugar above 110 mg/dL, diabetes, smoking, and 
antihypertensive medication (noted as Tx). You will only see what is on the left-hand side. 
Number 2 represents what is known as an ecological interface or display. It is made 
up of section 1, or the number line format, as well as the three other sections. The first 
represents the mathematical function used for calculating 10-year CVD risk according to the 
Framingham model and a contribution bar chart graphic demonstrating the unique 
contribution of each risk factor to 10-year risk. The bottom bar graph represents the risk 
factors that increase risk for this patient while the top bar represents the factors that 
decrease risk for this patient. The line projected off the top bar meets with the Framingham 
function and indicates the 10-year risk. The lateral projection line takes us to the next area 
of the display, or the area representing the ATP-III guidelines. The multicolored box 
represents the decision rules advised by the ATP-III as a function of 10 year risk and LDL 
cholesterol. Red represents the region associated with drug therapy, yellow with 
therapeutic lifestyle changes, and green with no treatment. According to the ATP-3 
guidelines, existing HD and diabetes will automatically place a patient in the high-risk 
region, even though the calculated risk may be lower. This is represented by extending the 
line up from LDL to place a point in the high risk region.  
The pentagons underneath simply keep track of the number of treatment modifying 
risk factors and the number of factors that contribute to metabolic syndrome. As these 
conditions are met, these segments of each pentagon will fill up until they meet their 
thresholds and will turn red to indicate that enough factors are present to modify goals and 
treatment or that the patient may have metabolic syndrome.  
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The last area in this display represents the jnc-7 guidelines. Green represents health, 
yellow represents prehypertension, orange represents stage 1 hypertension, and red 
represents stage 2 hypertension.  
 Again, there are 12 answer sheets that correspond to 12 different patients—hence 
12 trials. The data from each patient trial will be in one of two graphical formats. Please 
answer to the best of your abilities, make notes if you need to, and please do not go back to 




CVD Risk Display Usability Protocol:  
Dynamic Display Evaluation & Interview 
 
1. Obtain consent to record video and audio 
2. Read General Instructions 
i. I will provide you with data from two sets of patients. Please evaluate the data 
and make a decision regarding treatment for these patients’ cardiovascular 
health. You will have 10 minutes to review each set of patients. At the end of 
both sets, you will get a chance to go back and review any of the patients that 
you have already examined and have a chance to change your answers. 
ii.  As you review the data from each patient, please speak your thoughts out loud 
as if you were explaining your reasoning and decisions to a medical student or 
resident. Additionally, we would like you to provide a ranking of how confident 
you feel that your decision matches that of the JNC-7 and ATP-III guidelines. 
This ranking is on a scale from 1 to 7, where 1 is “not at all confident” to 7 
being “completely confident.”  
3. Number line Format 
a. Read instructions 
i. You are to imagine that you have added six new male patients to your practice 
yesterday. You ordered lipid panels for these patients as part of the 
examinations. You were also able to have some of the patients’ medical 
information transferred over from their previous physicians. Today, the 
results have returned from the lab and it is now time to review them and make 
decisions about how to proceed.  
b. Give example number line format 
i. This is patient data presented in a number line format. ExtHD means existing 
heart disease, which in this case means clinical CHD, symptomatic carotid 
artery disease, PAD, or abdominal aortic aneurysm. FamHx is family history of 
coronary heart disease, specifically meaning a 1st degree relative with CHD; 
male < 55 or female < 65. This is whether the waist circumference is greater 
than 40 inches or 102 cm. This is the fasting blood glucose level and whether it 
is greater than or equal to 110mg/dL. The reported blood pressure reflects the 
average pressure over many past readings. **Explain the rest.**  
c. You will have 10 minutes to review as many of these patients as possible. Please work as 
quickly and as accurately as possible.  Do you have any questions? 
d. Allow 10 minutes for number line task completion  
4. Ecological Display Format 
a. Read instructions 
i. This portion will proceed exactly as the previous portion, where you will 
review the data from six different patients. Please continue to speak your 
thoughts out loud and rank the confidence in your answers.
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b. Give example of ecological format and demonstrate 
i. This is patient data presented in what is known as an ecological display, which 
means that attempts have been made to display the data within the context of 
the scientific evidence and treatment guidelines. This is an interactive display, 
so feel free to explore it by using the mouse as I explain the various 
components. The left hand side is the number line format from the previous 
task. You can click on the arrows and make adjustments to these values and 
have their effects displayed elsewhere in the interface. This part is a graphical 
representation of the Framingham model of cardiovascular risk. This is a 
contribution graphic for the risk factors and their influence on risk. The 
bottom bar is comprised of all of the risk factors that increase risk for this 
patient and the top bar is comprised of the factors that reduce risk for this 
patient. The colors in these bars correspond to the factors in the number line 
portion of the display. Clicking on the I icon will allow you to see each of these 
risk factors in terms of the most detrimental to the most beneficial for this 
patient. Clicking it again will return it back the contribution bars. If you 
project a line from the top bar up into the curve, you get the 10-year risk for 
this patient. If you project a horizontal line from this point, you end up in the 
ATP-III treatment options matrix. This matrix is a graphical representation of 
the ATP-III guidelines for treating cholesterol. If you find the patient’s LDL 
cholesterol level and draw a line up to intersect with the horizontal line from 
the 10-year risk, you create a set of coordinates in this matrix. If this point is in 
the red area, the ATP-III guidelines suggest drug therapy for treating 
cholesterol. If it falls in the yellow area, it suggests therapeutic lifestyle 
changes, and if it falls in the green, then no treatment for cholesterol is 
suggested.  In this ATP-III area, there are also two pentagons. The first is a 
running total of factors that could constitute metabolic syndrome. The second 
is comprised of the factors that would modify treatment goals. If this turns red, 
then the treatment option matrix changes shape indicating the suggested 
treatment changes. The final area represents the JNC-7 guidelines for treating 
high blood pressure. This bar is scaled to the levels of severity. The green area 
is the healthy range, the yellow indicates prehypertension, the orange 
indicates Stage 1 hypertension, and the red represents Stage 2 hypertension.  
c. You will have 10 minutes to review as many of these patients as possible. Again, please 
work as quickly and as accurately as possible.  Do you have any questions?   
d. Allow 10 minutes for ECO task completion 
5. Free response 
a. Instructions 
i. Now that you have completed both tasks, you may go back and review any of 
the previous patients that you have reviewed.  
ii. If the physician goes back to review previous cases, then ask: 
1. What is it about this display that makes you want to revisit it?  
2. Would you change your confidence rating? To what? 
6. Interview physician 
a. Would you use the ecological format in your practice? 
b. What do you think is confusing about the ecological display? 
i. Is it something that training could resolve? 
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